FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Myron Levine

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Geographic Areas

Chile

Co-author Network

Publications

TOP 3
Brianna Lindsay; Dramane Malle; Carolyn R Morris; James P Nataro; John B Ochieng; Joe Oundo; Sandra Panchalingam; Mihai Pop; David A Rasko; Halvor Sommerfelt; Dilruba Ahmed; Martin Antonio; Stephen M Becker; Michel Dione; Barry S Fields; Anowar Hossain; Eric Houpt; Usman N Ikumapayi; Jane Juma; Karen L Kotloff; Myron M Levine; Shan Li; Boubou Tamboura; Aliou Toure; O Colin Stine
Quantitative PCR for Detection of Shigella Improves Ascertainment of Shigella Burden in Children with Moderate-to-Severe Diarrhea in Low-Income Countries.
Eileen M Barry; Alessio Fasano; Karen L Kotloff; Marcela F Pasetti; Marcelo B Sztein; Myron M Levine
Progress and pitfalls in Shigella vaccine research.
Satarupa Mullick; James P Nataro; Gururaja Perumal Pazhani; Thandavarayan Ramamurthy; Dipika Sur; Santanu Ghosh; Myron M Levine; Byomkesh Manna; Anupam Mukherjee; Mamta Chawla-Sarkar
Genomic analysis of human rotavirus strains G6P[14] and G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Myron Levine (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brianna Lindsay; Dramane Malle; Carolyn R Morris; James P Nataro; John B Ochieng; Joe Oundo; Sandra Panchalingam; Mihai Pop; David A Rasko; Halvor Sommerfelt; Dilruba Ahmed; Martin Antonio; Stephen M Becker; Michel Dione; Barry S Fields; Anowar Hossain; Eric Houpt; Usman N Ikumapayi; Jane Juma; Karen L Kotloff; Myron M Levine; Shan Li; Boubou Tamboura; Aliou Toure; O Colin Stine
Quantitative PCR for Detection of Shigella Improves Ascertainment of Shigella Burden in Children with Moderate-to-Severe Diarrhea in Low-Income Countries.
Journal of clinical microbiology 2013;51(6):1740-6.
2013: Eileen M Barry; Alessio Fasano; Karen L Kotloff; Marcela F Pasetti; Marcelo B Sztein; Myron M Levine
Progress and pitfalls in Shigella vaccine research.
Nature reviews. Gastroenterology & hepatology 2013;10(4):245-55.
2013: Satarupa Mullick; James P Nataro; Gururaja Perumal Pazhani; Thandavarayan Ramamurthy; Dipika Sur; Santanu Ghosh; Myron M Levine; Byomkesh Manna; Anupam Mukherjee; Mamta Chawla-Sarkar
Genomic analysis of human rotavirus strains G6P[14] and G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2013;14():15-21.
2013: Maria Fiorentino; Karen Lammers; Myron M Levine; Marcelo B Sztein; Alessio Fasano
In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines.
Frontiers in immunology 2013;4():17.
2012: Andrew J Pollard; Robert C Read; Julian Savulescu; Wellington Sun; David Y Graham; Adrian Vs Hill; Myron M Levine; David Jm Lewis; Peter Openshaw; John Oxford; Stephen B Gordon
Human microbial challenge: the ultimate animal model.
The Lancet infectious diseases 2012;12(12):903-5.
2012: Richard Rheingans; Dipika Sur; Anita K M Zaidi; Tamer H Farag; Abu Syed Golam Faruque; Matt Kukla; Myron M Levine; Dilruba Nasrin; Karen L Kotloff
Determinants of household costs associated with childhood diarrhea in 3 South Asian settings.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S327-35.
2012: Richard Rheingans; Debasish Saha; Samba O Sow; Dilruba Nasrin; Richard Omore; Uma Onwuchekwa; Richard A Adegbola; Robert F Breiman; Tamer H Farag; Karen L Kotloff; Matt Kukla; Myron M Levine
Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S317-26.
2012: Roy M Robins-Browne; Myron M Levine
Laboratory diagnostic challenges in case/control studies of diarrhea in developing countries.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S312-6.
2012: Myron M Levine; Roy M Robins-Browne
Factors that explain excretion of enteric pathogens by persons without diarrhea.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S303-11.
2012: Sandra Panchalingam; William Petri; Valeria Prado; T Ramamurthy; Roy M Robins-Browne; Philippe Sansonetti; Duncan Steele; Nancy Strockbine; Ann-Marie Svennerholm; Boubou Tamboura; Marija Tauschek; Roberto Vidal; Anita K M Zaidi; Martin Antonio; Roger I Glass; Anowar Hossain; Eric Houpt; Karen L Kotloff; Myron M Levine; Inacio Mandomando; Patrick Murray; Ben Ochieng; Joseph Oundo; James P Nataro
Diagnostic microbiologic methods in the GEMS-1 case/control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S294-302.
2012: Khitam Muhsen; Myron M Levine
A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S271-93.
2012: Halvor Sommerfelt; Hans Steinsland; Lize van der Merwe; William C Blackwelder; Tamer H Farag; Karen L Kotloff; Myron M Levine; Dilruba Nasrin; Håkon K Gjessing
Case/control studies with follow-up: Constructing the source population to estimate effects of risk factors on development, disease, and survival.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S262-70.
2012: Kousick Biswas; Christina Carty; Tamer H Farag; Rebecca Horney; Karen L Kotloff; Dilruba Nasrin; Myron M Levine
Data management and other logistical challenges for the GEMS: the data coordinating center perspective.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S254-61.
2012: William C Blackwelder; Tamer H Farag; Barry I Graubard; Karen L Kotloff; Dilruba Nasrin; Halvor Sommerfelt; Yukun Wu; Kousick Biswas; Myron M Levine
Statistical methods in the Global Enteric Multicenter Study (GEMS).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S246-53.
2012: Karen L Kotloff; Richard A Adegbola; Pedro L Alonso; Kousick Biswas; William C Blackwelder; Robert F Breiman; John D Clemens; Dani Cohen; Tamer H Farag; Roger I Glass; Eric D Mintz; Dilruba Nasrin; James P Nataro; Sandra Panchalingam; Debasish Saha; Halvor Sommerfelt; Samba O Sow; Dipika Sur; Annemieke van Eijk; Anita K M Zaidi; Abu Syed Golam Faruque; Myron M Levine
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S232-45.
2012: Tamer H Farag; Karen L Kotloff; William C Blackwelder; Khitam Muhsen; Dilruba Nasrin; James P Nataro; Sandra Panchalingam; Halvor Sommerfelt; Yukun Wu; Myron M Levine
Some epidemiologic, clinical, microbiologic, and organizational assumptions that influenced the design and performance of the Global Enteric Multicenter Study (GEMS).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S225-31.
2012: Myron M Levine; Karen L Kotloff; James P Nataro; Khitam Muhsen
The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 4():S215-24.
2012: Chinyere K Okoro; Julian Parkhill; Christopher M Parry; Milagritos D Tapia; Sharon Tennant; John Wain; Manar N Al-Mashhadani; Pedro L Alonso; Thomas R Connor; Elizabeth de Pinna; Melita A Gordon; Simon R Harris; Robert S Heyderman; Samuel Kariuki; Robert A Kingsley; Myron M Levine; Calman A MacLennan; Inacio Mandomando; Chisomo L Msefula; Stephen Obaro; Gordon Dougan
Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa.
Nature genetics 2012;44(11):1215-21.
2012: Marcela F Pasetti; Myron M Levine
Insights from natural infection-derived immunity to cholera instruct vaccine efforts.
Clinical and vaccine immunology : CVI 2012;19(11):1707-11.
2012: Felipe Del Canto; Myron M Levine; James P Nataro; Mihai Pop; Vsevolod Popov; Fernando Ruiz-Perez; O Colin Stine; Alfredo G Torres; Patricio Valenzuela; Douglas J Botkin; Roberto Vidal
Identification of Coli Surface Antigen 23, a novel adhesin of enterotoxigenic Escherichia coli.
Infection and immunity 2012;80(8):2791-801.
2012: Julia Hutter; Marcela F Pasetti; Doh Sanogo; Samba O Sow; Milagritos D Tapia; Myron M Levine
Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
The American journal of tropical medicine and hygiene 2012;86(6):1026-31.
2012: Rezwanul Wahid; Shah J Zafar; Myron M Levine; Raphael Simon; Marcelo B Sztein
Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Clinical and vaccine immunology : CVI 2012;19(6):825-34.
2012: Milagritos D Tapia; John C Victor; George E Armah; Robert F Breiman; Max Ciarlet; Michael J Dallas; Daniel R Feikin; Kayla F Laserson; Myron M Levine; Kristen D C Lewis; Kathleen M Neuzil; Stephen B Rivers; Samba O Sow; Andrew Duncan Steele
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
Vaccine 2012;30 Suppl 1():A79-85.
2012: Samba O Sow; Andrew Duncan Steele; Milagritos D Tapia; Oumou Traoré; John C Victor; Kristen D C Lewis; Kathleen M Neuzil; Uma U Onwuchekwa; Max Ciarlet; Rokiatou D Dembélé; Fatoumata Diallo; Moussa Doumbia; Fadima C Haidara; Mamoudou Kodio; Karen L Kotloff; Myron M Levine
Efficacy of the oral pentavalent rotavirus vaccine in Mali.
Vaccine 2012;30 Suppl 1():A71-8.
2012: Raphael Simon; Myron M Levine
Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.
Human vaccines & immunotherapeutics 2012;8(4):494-8.
2012: Subrata Sabui; Dipika Sur; Anusuya Debnath; Sanjucta Dutta; Avishek Ghosh; Takashi Hamabata; Myron M Levine; James P Nataro; K Rajendran; Thandavarayan Ramamurthy; Nabendu Sekhar Chatterjee
Real-time PCR-based mismatch amplification mutation assay for specific detection of CS6-expressing allelic variants of enterotoxigenic Escherichia coli and its application in assessing diarrheal cases and asymptomatic controls.
Journal of clinical microbiology 2012;50(4):1308-12.
2012: Nadia Boisen; Julia C Redman; Boubou Tamboura; Sandra Panchalingam; Karen A Krogfelt; Jakub K Simon; Samba Sow; Dramane Malle; Aliou Toure; Flemming Scheutz; Myron M Levine; Søren Persson; David Rasko; Karen L Kotloff; James P Nataro
Genomic characterization of enteroaggregative Escherichia coli from children in Mali.
The Journal of infectious diseases 2012;205(3):431-44.
2012: Lauren A V Orenstein; Samba O Sow; Milagritos D Tapia; Ibrahima Teguete; Mamoudou Kodio; Evan W Orenstein; Myron M Levine
Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-Saharan Africa.
PloS one 2012;7(10):e46638.
2011: Myron M Levine
"IDEAL" vaccines for resource poor settings.
Vaccine 2011;29 Suppl 4():D116-25.
2011: Tao Wu; Christen Grassel; Myron M Levine; Eileen M Barry
Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
Infection and immunity 2011;79(12):4912-22.
2011: Jakub K Simon; Marcelo B Sztein; Bruce G Weniger; Marcela F Pasetti; James D Campbell; Mihaela Carter; Karen L Kotloff; Myron M Levine
Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector.
Vaccine 2011;29(51):9544-50.
2011: Orit Gat; William C Blackwelder; James E Galen; Marcela F Pasetti; David J Silverman; Raphael Simon; Sharon Tennant; Myron M Levine
Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
PLoS neglected tropical diseases 2011;5(11):e1373.
2011: Sharon Tennant; Jin-Yuan Wang; James E Galen; Orit Gat; Marcela F Pasetti; Raphael Simon; Myron M Levine
Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
Infection and immunity 2011;79(10):4175-85.
2011: Raphael Simon; Sharon Tennant; Jin Y Wang; Marcela F Pasetti; Patrick J Schmidlein; Robert Ernst; James E Galen; Andrew Lees; Myron M Levine
Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
Infection and immunity 2011;79(10):4240-9.
2011: Felipe Del Canto; Myron M Levine; James P Nataro; Valeria Prado; Halvor Sommerfelt; Patricio Valenzuela; Jorge Blanco; Jesús E Blanco; Jonathan Bronstein; Lidia Cantero; Roberto Vidal
Distribution of classical and nonclassical virulence genes in enterotoxigenic Escherichia coli isolates from Chilean children and tRNA gene screening for putative insertion sites for genomic islands.
Journal of clinical microbiology 2011;49(9):3198-203.
2011: Raphael Simon; Sharon Tennant; James E Galen; Myron M Levine
Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.
Vaccine 2011;29(32):5094-106.
2011: Inacio Mandomando; Denise Naniche; Delino Nhalungo; Marcela F Pasetti; Sergi Sanz; Betuel Sigauque; Xavier Vallès; Lilian Cuberos; Karen L Kotloff; Myron M Levine; Eusebio Macete; Pedro L Alonso
Assessment of the epidemiology and burden of measles in Southern Mozambique.
The American journal of tropical medicine and hygiene 2011;85(1):146-51.
2011: Rosanna E Lagos; Myron M Levine; Alma E Muñoz; Juan Pablo Yarzabal; Nancy François; Alejandro Lepetic; Lode Schuerman
Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children.
Human vaccines 2011;7(5):511-22.
2011: Jakub K Simon; Milton Jr. Maciel; Ethel Weld; Rezwanul Wahid; Marcela F Pasetti; W L Picking; Karen L Kotloff; Myron M Levine; Marcelo B Sztein
Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.
Clinical immunology (Orlando, Fla.) 2011;139(2):185-92.
2011: Jakub K Simon; Karina Ramirez; Lilian Cuberos; James D Campbell; Jean F Viret; Alma Muñoz; Rosanna Lagos; Myron M Levine; Marcela F Pasetti
Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
Clinical and vaccine immunology : CVI 2011;18(3):355-61.
2011: Myron M Levine; Tamer H Farag
Invasive salmonella infections and HIV in Northern Tanzania.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(3):349-51.
2011: Rezwanul Wahid; Marcela F Pasetti; Milton Jr. Maciel; Jakub K Simon; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
Clinical immunology (Orlando, Fla.) 2011;138(2):187-200.
2011: Sharon Tennant; Yongxia Zhang; James E Galen; Chris D Geddes; Myron M Levine
Ultra-fast and sensitive detection of non-typhoidal Salmonella using microwave-accelerated metal-enhanced fluorescence ("MAMEF").
PloS one 2011;6(4):e18700.
2011: Joel G Breman; Ciro A de Quadros; Walter R Dowdle; William H Foege; Donald A Henderson; T Jacob John; Myron M Levine
The role of research in viral disease eradication and elimination programs: lessons for malaria eradication.
PLoS medicine 2011;8(1):e1000405.
2011: Pedro L Alonso; Graham Brown; Myriam Arevalo-Herrera; Fred Binka; Chetan E Chitnis; Frank Collins; Ogobara K Doumbo; Brian Greenwood; B Fenton Hall; Myron M Levine; Kamini Mendis; Robert D Newman; Christopher Plowe; Mario Henry Rodríguez; Robert Sinden; Laurence Slutsker; Marcel Tanner
A research agenda to underpin malaria eradication.
PLoS medicine 2011;8(1):e1000406.
2011: Marcela F Pasetti; Jakub K Simon; Marcelo B Sztein; Myron M Levine
Immunology of gut mucosal vaccines.
Immunological reviews 2011;239(1):125-48.
2010: Gregory A Poland; Myron M Levine; John D Clemens
Developing the next generation of vaccinologists.
Vaccine 2010;28(52):8227-8.
2010: George E Armah; Samba O Sow; Robert Breiman; Michael J Dallas; Milagritos D Tapia; Daniel R Feikin; Fred Binka; Andrew Duncan Steele; Kayla F Laserson; Nana A Ansah; Myron M Levine; Kristen Lewis; Michele L Coia; Margaret Attah-Poku; Joel Ojwando; Stephen B Rivers; John C Victor; Geoffrey Nyambane; Abraham Hodgson; Florian Schödel; Max Ciarlet; Kathleen M Neuzil
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
Lancet 2010;376(9741):606-14.
2010: Steven T Shipley; Aruna Panda; Abdul Q Khan; Edwin H Kriel; Milton Jr. Maciel; Sofie Livio; James P Nataro; Myron M Levine; Marcelo B Sztein; Louis J DeTolla
A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis).
Comparative medicine 2010;60(1):54-61.
2010: Myron M Levine
Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.
BMC biology 2010;8():129.
2010: Sharon Tennant; Souleymane Diallo; Haim Levy; Sofie Livio; Samba O Sow; Milagritos D Tapia; Patricia I Fields; Matthew Mikoleit; Boubou Tamboura; Karen L Kotloff; James P Nataro; James E Galen; Myron M Levine
Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali.
PLoS neglected tropical diseases 2010;4(3):e621.
2010: James E Galen; Jin Yuan Wang; Magaly Chinchilla; Christofer J Vindurampulle; Jeffrey E Vogel; Haim Levy; William C Blackwelder; Marcela F Pasetti; Myron M Levine
A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors.
Infection and immunity 2010;78(1):337-47.
2009: Inacio Mandomando; Eusebio Macete; Betuel Sigaúque; Luis Morais; Llorenç Quintó; Jahit Sacarlal; Mateu Espasa; Xavier Vallès; Quique Bassat; Pedro Aide; Tacilta Nhampossa; Sonia Machevo; Joaquin Ruiz; Ariel Q Nhacolo; Clara Menéndez; Karen L Kotloff; Anna Roca; Myron M Levine; Pedro L Alonso
Invasive non-typhoidal Salmonella in Mozambican children.
Tropical medicine & international health : TM & IH 2009;14(12):1467-74.
2009: Roberto M Vidal; Patricio Valenzuela; Kelly K Baker; Rosanna Lagos; Mario Esparza; Sofie Livio; Mauricio Farfán; James P Nataro; Myron M Levine; Valeria Prado
Characterization of the most prevalent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains using a new multiplex polymerase chain reaction.
Diagnostic microbiology and infectious disease 2009;65(3):217-23.
2009: Rosanna Lagos; Alma Muñoz; Aníbal Espinoza; Angela Dowes; Ricardo Ruttimann; Rómulo Colindres; Myron M Levine
[Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children].
Revista panamericana de salud pública = Pan American journal of public health 2009;26(2):101-11.
2009: Myron M Levine
Typhoid vaccines ready for implementation.
The New England journal of medicine 2009;361(4):403-5.
2009: James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Salmonella enterica serovar Typhi live vector vaccines finally come of age.
Immunology and cell biology 2009;87(5):400-12.
2009: Samba O Sow; Milagritos D Tapia; Souleymane Diallo; Mamadou Marouf Keita; Mariam Sylla; Uma Onwuchekwa; Marcela F Pasetti; Karen L Kotloff; Myron M Levine
Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
The American journal of tropical medicine and hygiene 2009;80(6):1033-8.
2009: Myron M Levine; Roy Robins-Browne
Vaccines, global health and social equity.
Immunology and cell biology 2009;87(4):274-8.
2009: K K Baker; Myron M Levine; J Morison; A Phillips; Eileen M Barry
CfaE tip mutations in enterotoxigenic Escherichia coli CFA/I fimbriae define critical human intestinal binding sites.
Cellular microbiology 2009;11(5):742-54.
2009: Araceli E Santiago; Leah E Cole; Augusto A. Franco-Mora; Stefanie N Vogel; Myron M Levine; Eileen M Barry
Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.
Vaccine 2009;27(18):2426-36.
2009: Rosanna Lagos; Alma Munoz; Myron M Levine; Wendy Watson; Ih Chang; Peter Paradiso
Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants.
Vaccine 2009;27(17):2299-305.
2009: Marcela F Pasetti; Karina Ramirez; Aldo Resendiz-Albor; Jeffrey Ulmer; Eileen M Barry; Myron M Levine
Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
Journal of virology 2009;83(6):2789-94.
2009: Betuel Sigaúque; Anna Roca; Inacio Mandomando; Luís Morais; Llorenç Quintó; Jahit Sacarlal; Eusebio Macete; Tacilta Nhamposa; Sónia Machevo; Pedro Aide; Quique Bassat; Azucena Bardají; Delino Nhalungo; montse soriano-gabarró; Brendan Flannery; Clara Menendez; Myron M Levine; Pedro L Alonso
Community-acquired bacteremia among children admitted to a rural hospital in Mozambique.
The Pediatric infectious disease journal 2009;28(2):108-13.
2009: James E Galen; Magaly Chinchilla; Marcela F Pasetti; Jin Yuan Wang; Licheng Zhao; Ivonne Arciniega-Martinez; David J Silverman; Myron M Levine
Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine.
The Journal of infectious diseases 2009;199(3):326-35.
2009: Jakub K Simon; Rezwanul Wahid; Milton Jr. Maciel; W L Picking; Karen L Kotloff; Myron M Levine; Marcelo B Sztein
Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates.
Vaccine 2009;27(4):565-72.
2008: Rosanna Lagos; Alma Muñoz; Oriana San Martin; Aurora Maldonado; Juan Carlos Hormazabal; William C Blackwelder; Myron M Levine
Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.
The Journal of infectious diseases 2008;198(12):1809-17.
2008: Inacio Mandomando; Denise Naniche; Marcela F Pasetti; Xavier Vallès; Lilian Cuberos; Ariel Q Nhacolo; Karen L Kotloff; Helder Martins; Myron M Levine; Pedro Alonso
Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk.
The American journal of tropical medicine and hygiene 2008;79(5):787-92.
2008: Chee-Mun Fang; Jin Yuan Wang; Magaly Chinchilla; Myron M Levine; William C Blackwelder; James E Galen
Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.
Infection and immunity 2008;76(10):4422-30.
2008: Rezwanul Wahid; Rosangela Noberga Mezghanni; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.
Mucosal immunology 2008;1(5):389-98.
2008: Anna Roca; Llorenç Quintó; Fatima Abacassamo; Luis Morais; Xavi Vallès; Mateu Espasa; Betuel Sigaúque; Jahit Sacarlal; Eusebio Macete; Ariel Nhacolo; Inacio Mandomando; Myron M Levine; Pedro L Alonso
Invasive Haemophilus influenzae disease in children less than 5 years of age in Manhiça, a rural area of southern Mozambique.
Tropical medicine & international health : TM & IH 2008;13(6):818-26.
2008: Karina Ramirez; Eileen M Barry; Jeffrey Ulmer; Richard Stout; James Szabo; Timothy Scott Manetz; Myron M Levine; Marcela F Pasetti
Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.
Human gene therapy 2008;19(5):522-31.
2008: Haim Levy; Souleymane Diallo; Sharon Tennant; Sofie Livio; Samba O Sow; Milagritos D Tapia; Patricia I Fields; Matthew Mikoleit; Boubou Tamboura; Karen L Kotloff; Rosanna Lagos; James P Nataro; James E Galen; Myron M Levine
PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B among Salmonella Isolates from the blood of patients with clinical enteric fever.
Journal of clinical microbiology 2008;46(5):1861-6.
2008: William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Enteric infections, diarrhea, and their impact on function and development.
The Journal of clinical investigation 2008;118(4):1277-90.
2008: Alan S Cross; Wilbur H Chen; Myron M Levine
A case for immunization against nosocomial infections.
Journal of leukocyte biology 2008;83(3):483-8.
2008: Betuel Sigaúque; Anna Roca; Sergi Sanz; I Oliveiras; M Martínez; Inacio Mandomando; Xavier Vallès; Mateu Espasa; Fátima Abacassamo; Jahit Sacarlal; Eusebio Macete; Ariel Q Nhacolo; John J Aponte; Myron M Levine; Pedro L Alonso
Acute bacterial meningitis among children, in Manhiça, a rural area in Southern Mozambique.
Acta tropica 2008;105(1):21-7.
2007: Marcela F Pasetti; A Resendiz-Albor; K Ramirez; R Stout; M Papania; Robert J Adams; Fernando P Polack; brian ward; David Burt; Sophie Chabot; Jeffrey Ulmer; Eileen M Barry; Myron M Levine
Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
Clinical pharmacology and therapeutics 2007;82(6):672-85.
2007: Inacio Mandomando; Betuel Sigaúque; Xavier Vallès; Mateu Espasa; Sergi Sanz; Jahit Sacarlal; Eusebio Macete; Fátima Abacassamo; Joaquin Ruiz; Joaquim Gascon; Karen L Kotloff; Myron M Levine; Pedro L Alonso
Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique.
The Pediatric infectious disease journal 2007;26(11):1059-61.
2007: Karen L Kotloff; Jakub K Simon; Marcela F Pasetti; Marcelo B Sztein; Stacey L Wooden; Sofie Livio; James P Nataro; William C Blackwelder; Eileen M Barry; William D Picking; Myron M Levine
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media.
Human vaccines 2007;3(6):268-75.
2007: Magaly Chinchilla; Marcela F Pasetti; Sandra Medina-Moreno; Jin Yuan Wang; OG Gómez-Duarte; Rick Stout; Myron M Levine; James E Galen
Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
Infection and immunity 2007;75(8):3769-79.
2007: Myron M Levine; Catterine Ferreccio; Robert E Black; Rosanna Lagos; Oriana San Martin; William C Blackwelder
Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45 Suppl 1():S24-8.
2007: Carol O Tacket; Myron M Levine
CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45 Suppl 1():S20-3.
2007: Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.
Nature reviews. Microbiology 2007;5(7):540-53.
2007: Jakub K Simon; Marcela F Pasetti; Jean-François Viret; Robert Mischler; Alma Muñoz; Rosanna Lagos; Myron M Levine; James D Campbell
A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
Human vaccines 2007;3(2):54-8.
2007: Rezwanul Wahid; Rosangela Noberga Mezghanni; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.
Vaccine 2007;25(8):1416-25.
2007: Myron M Levine
University of Maryland, Baltimore's participation in global health.
Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society 2007;8(3):27-9.
2006: Milagritos D Tapia; Marcela F Pasetti; Lilian Cuberos; Samba O Sow; Mama N Doumbia; Modibo Bagayogo; Karen L Kotloff; Myron M Levine
Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys.
The Pediatric infectious disease journal 2006;25(9):819-25.
2006: Anna Roca; Betuel Sigaúque; Llorenç Quintó; Inacio Mandomando; Xavier Vallès; Mateu Espasa; Fátima Abacassamo; Jahit Sacarlal; Eusebio Macete; Ariel Q Nhacolo; Myron M Levine; Pedro Alonso
Invasive pneumococcal disease in children<5 years of age in rural Mozambique.
Tropical medicine & international health : TM & IH 2006;11(9):1422-31.
2006: Rosanna M Lagos; Alma E Muñoz; Myron M Levine
Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), Chile.
Human vaccines 2006;2(3):129-33.
2006: Alejandra V E Capozzo; Karina Ramírez; John M Polo; Jeffrey Ulmer; Eileen M Barry; Myron M Levine; Marcela F Pasetti
Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5671-81.
2006: Myron M Levine
Enteric infections and the vaccines to counter them: future directions.
Vaccine 2006;24(18):3865-73.
2006: Eileen M Barry; Jin Wang; Tao Wu; Tamar Davis; Myron M Levine
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Vaccine 2006;24(18):3727-34.
2006: Xavier Vallès; Brendan Flannery; Anna Roca; Inacio Mandomando; Betuel Sigaúque; Sergi Sanz; Anne Schuchat; Myron M Levine; montse soriano-gabarró; Pedro Alonso
Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique.
Tropical medicine & international health : TM & IH 2006;11(3):358-66.
2006: Myron M Levine
Mass vaccination to control epidemic and endemic typhoid fever.
Current topics in microbiology and immunology 2006;304():231-46.
2005: Maricel Vidal; Eileen Kruger; Claudia Durán; Rosanna Lagos; Myron M Levine; Valeria Prado; Cecilia Toro; Roberto Vidal
Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections.
Journal of clinical microbiology 2005;43(10):5362-5.
2005: Man Ki Song; Christofer J Vindurampulle; Alejandra V E Capozzo; Jeffrey Ulmer; John M Polo; Marcela F Pasetti; Eileen M Barry; Myron M Levine
Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Journal of virology 2005;79(15):9854-61.
2005: Milagritos D Tapia; Samba O Sow; Sandra Medina-Moreno; Yu Lim; Marcela F Pasetti; Karen L Kotloff; Myron M Levine
A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali.
The American journal of tropical medicine and hygiene 2005;73(1):26-31.
2005: Noelia Fullá; Valeria Prado; Claudia Durán; Rosanna Lagos; Myron M Levine
Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of santiago, chile.
The American journal of tropical medicine and hygiene 2005;72(6):851-4.
2005: Samba O Sow; Souleymane Diallo; James D Campbell; Milagritos D Tapia; Tatiana Keita; Mamadou Marouf Keita; Patrick Murray; Karen L Kotloff; Myron M Levine
Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
The Pediatric infectious disease journal 2005;24(6):533-7.
2005: Rosanna Lagos; Agnès Hoffenbach; Michel Scemama; Martin Dupuy; Florian Schodel; Luc Hessel; Myron M Levine
Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age.
Human vaccines 2005;1(3):112-7.
2005: Myron M Levine; Philippe Lepage
Prevention of typhoid fever.
Advances in experimental medicine and biology 2005;568():161-73.
2004: James E Galen; Licheng Zhao; Magaly Chinchilla; Jin Yuan Wang; Marcela F Pasetti; Jeffrey Green; Myron M Levine
Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
Infection and immunity 2004;72(12):7096-106.
2004: Karen L Kotloff; Marcela F Pasetti; Eileen M Barry; James P Nataro; Steven Wasserman; Marcelo B Sztein; William D Picking; Myron M Levine
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
The Journal of infectious diseases 2004;190(10):1745-54.
2004: Christofer J Vindurampulle; Lilian Cuberos; Eileen M Barry; Marcela F Pasetti; Myron M Levine
Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
Vaccine 2004;22(27-28):3744-50.
2004: Alejandra V E Capozzo; Lilian Cuberos; Myron M Levine; Marcela F Pasetti
Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
Infection and immunity 2004;72(8):4637-46.
2004: Carol O Tacket; Marcela F Pasetti; Marcelo B Sztein; Sofie Livio; Myron M Levine
Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
The Journal of infectious diseases 2004;190(3):565-70.
2004: James D Campbell; Karen L Kotloff; Samba O Sow; Milagritos D Tapia; Mamadou Marouf Keita; Tatiana Keita; Souleymane Diallo; Juan Carlos Hormazabal; Patrick Murray; Myron M Levine
Invasive pneumococcal infections among hospitalized children in Bamako, Mali.
The Pediatric infectious disease journal 2004;23(7):642-9.
2004: James D Campbell; Samba O Sow; Myron M Levine; Karen L Kotloff
The causes of hospital admission and death among children in Bamako, Mali.
Journal of tropical pediatrics 2004;50(3):158-63.
2004: Neil R Wyborn; Angela Clark; Ruth E Roberts; Stuart J Jamieson; Svetomir B Tzokov; Per A Bullough; Timothy J Stillman; Peter J Artymiuk; James E Galen; Licheng Zhao; Myron M Levine; Jeffrey Green
Properties of haemolysin E (HlyE) from a pathogenic Escherichia coli avian isolate and studies of HlyE export.
Microbiology (Reading, England) 2004;150(Pt 5):1495-505.
2004: Myron M Levine; Marcelo B Sztein
Vaccine development strategies for improving immunization: the role of modern immunology.
Nature immunology 2004;5(5):460-4.
2004: Roberto Vidal; Maricel Vidal; Rosanna Lagos; Myron M Levine; Valeria Prado
Multiplex PCR for diagnosis of enteric infections associated with diarrheagenic Escherichia coli.
Journal of clinical microbiology 2004;42(4):1787-9.
2004: Eric Mallet; Bernd H Belohradsky; Rosanna Lagos; Leif Gothefors; Patrice Camier; Jean-Pierre Carrière; Güler Kanra; Agnès Hoffenbach; Jacques Langue; François Undreiner; François Roussel; Philippe Reinert; Carl-Erik Flodmark; Silvia Stojanov; Johannes G Liese; Myron M Levine; Alma Muñoz; Florian Schodel; Luc Hessel
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
Vaccine 2004;22(11-12):1343-57.
2004: Yanwen Li; Yao-hui Sun; Catherine A Ison; Myron M Levine; Christoph M Tang
Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.
Infection and immunity 2004;72(1):345-51.
2003: Myron M Levine
Use of vaccines for the prevention of typhoid fever.
Indian pediatrics 2003;40(11):1029-34.
2003: Rosanna Lagos; Alma Munoz; Rafaele Dumas; Sylvie Pichon; Betzana Zambrano; Myron M Levine; Emmanuel Vidor
Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
Vaccine 2003;21(25-26):3730-3.
2003: Marcela F Pasetti; Eileen M Barry; Genevieve A Losonsky; Mahender Singh; Sandra Medina-Moreno; John M Polo; Jeffrey Ulmer; Harriet Robinson; Marcelo B Sztein; Myron M Levine
Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Journal of virology 2003;77(9):5209-17.
2003: Zeev Altboum; Myron M Levine; James E Galen; Eileen M Barry
Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain.
Infection and immunity 2003;71(3):1352-60.
2003: Rosangela Noberga Mezghanni; Timothy L Wyant; Marcela F Pasetti; Marcelo Fernandez-Viña; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2734-41.
2003: Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.
Vaccine 2003;21(5-6):401-18.
2003: Eileen M Barry; Zeev Altboum; Genevieve A Losonsky; Myron M Levine
Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.
Vaccine 2003;21(5-6):333-40.
2003: Myron M Levine
Can needle-free administration of vaccines become the norm in global immunization?
Nature medicine 2003;9(1):99-103.
2002: Rosanna Lagos; Alma Muñoz; María Teresa Valenzuela; Ingrid Heitmann; Myron M Levine
Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile.
The Pediatric infectious disease journal 2002;21(12):1115-23.
2002: James D Campbell; Rosanna Lagos; Myron M Levine; Genevieve A Losonsky
Standard and alternative regimens of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate vaccine) elicit comparable antibody avidities in infants.
The Pediatric infectious disease journal 2002;21(9):822-6.
2002: Fernando Ruiz-Perez; Rocío León-Kempis; Araceli Santiago-Machuca; Guadalupe Ortega-Pierres; Eileen M Barry; Myron M Levine; César González-Bonilla
Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL.
Infection and immunity 2002;70(7):3611-20.
2002: Claire Kidgell; Derek Pickard; John Wain; Keith James; L T Diem Nga; To Song Diep; Myron M Levine; Peadar Ó Gaora; Michael B Prentice; Julian Parkhill; Nicholas Day; Jeremy Farrar; Gordon Dougan
Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2.
Plasmid 2002;47(3):159-71.
2002: Karen L Kotloff; David N Taylor; Marcelo B Sztein; Steven Wasserman; Genevieve A Losonsky; James P Nataro; Malabi M Venkatesan; Antoinette Hartman; William D Picking; David E Katz; James D Campbell; Myron M Levine; Thomas L Hale
Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults.
Infection and immunity 2002;70(4):2016-21.
2002: INA STEPHENS; Myron M Levine
Management of typhoid fever in children.
The Pediatric infectious disease journal 2002;21(2):157-8.
2002: Myron M Levine; James D Campbell; Karen L Kotloff
Overview of vaccines and immunisation.
British medical bulletin 2002;62():1-13.
2001: Myron M Levine; Carol O Tacket; Marcelo B Sztein
Host-Salmonella interaction: human trials.
Microbes and infection / Institut Pasteur 2001;3(14-15):1271-9.
2001: James E Galen; Myron M Levine
Can a 'flawless' live vector vaccine strain be engineered?
Trends in microbiology 2001;9(8):372-6.
2001: Jin Yuan Wang; Marcela F Pasetti; FR Noriega; RJ Anderson; Steven Wasserman; James E Galen; Marcelo B Sztein; Myron M Levine
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
Infection and immunity 2001;69(8):4734-41.
2001: S Jean; K M LeVan; B Song; Myron M Levine; David M Knipe
Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.
Virology 2001;283(2):273-84.
2001: Zeev Altboum; Eileen M Barry; Genevieve A Losonsky; James E Galen; Myron M Levine
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Infection and immunity 2001;69(5):3150-8.
2001: Philip J Cooper; Martha E Chico; Carlos Sandoval; I Espinel; Angel Gustavo Guevara; Myron M Levine; George E Griffin; Thomas B Nutman
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.
Infection and immunity 2001;69(3):1574-80.
2001: N Orr; James E Galen; Myron M Levine
Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
Vaccine 2001;19(13-14):1694-700.
2001: OG Gómez-Duarte; Marcela F Pasetti; A Santiago; Marcelo B Sztein; S L Hoffman; Myron M Levine
Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.
Infection and immunity 2001;69(2):1192-8.
2000: KI Plaisance; S Kudaravalli; Steven Wasserman; Myron M Levine; Philip A Mackowiak
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections.
Pharmacotherapy 2000;20(12):1417-22.
2000: Carol O Tacket; James E Galen; Marcelo B Sztein; Genevieve A Losonsky; Timothy L Wyant; James P Nataro; Steven Wasserman; Robert Edelman; Steven N Chatfield; Gordon Dougan; Myron M Levine
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
Clinical immunology (Orlando, Fla.) 2000;97(2):146-53.
2000: Myron M Levine
Immunization against bacterial diseases of the intestine.
Journal of pediatric gastroenterology and nutrition 2000;31(4):336-55.
2000: Philip J Cooper; Martha E Chico; Genevieve A Losonsky; Carlos Sandoval; I Espinel; R Sridhara; M Aguilar; Angel Gustavo Guevara; Ronald H Guderian; Myron M Levine; George E Griffin; Thomas B Nutman
Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 2000;182(4):1199-206.
2000: Shaoguang Wu; M Beier; Marcelo B Sztein; James E Galen; TE Pickett; A A Holder; OG Gómez-Duarte; Myron M Levine
Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.
Journal of biotechnology 2000;83(1-2):125-35.
2000: H Koprowski; Myron M Levine; RJ Anderson; Genevieve A Losonsky; M Pizza; Eileen M Barry
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
Infection and immunity 2000;68(9):4884-92.
2000: Jin Yuan Wang; FR Noriega; James E Galen; Eileen M Barry; Myron M Levine
Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
Infection and immunity 2000;68(8):4647-52.
2000: Marcela F Pasetti; TE Pickett; Myron M Levine; Marcelo B Sztein
A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.
Vaccine 2000;18(28):3208-13.
2000: Carol O Tacket; Hugh S Mason; Genevieve A Losonsky; M K Estes; Myron M Levine; Charles J Arntzen
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.
The Journal of infectious diseases 2000;182(1):302-5.
2000: Carol O Tacket; Marcelo B Sztein; Genevieve A Losonsky; A Abe; B B Finlay; BP McNamara; George T Fantry; Stephen P James; James P Nataro; Myron M Levine; Michael S Donnenberg
Role of EspB in experimental human enteropathogenic Escherichia coli infection.
Infection and immunity 2000;68(6):3689-95.
2000: E E Richie; Narain H Punjabi; Y Y Sidharta; K K Peetosutan; M M Sukandar; Steven Wasserman; Murad Lesmana; Ferry Wangsasaputra; S S Pandam; Myron M Levine; P P O'Hanley; Stanley J Cryz; Cyrus H Simanjuntak
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.
Vaccine 2000;18(22):2399-410.
2000: RJ Anderson; Marcela F Pasetti; Marcelo B Sztein; Myron M Levine; FR Noriega
DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.
Vaccine 2000;18(21):2193-202.
2000: Carol O Tacket; Marcelo B Sztein; Steven Wasserman; Genevieve A Losonsky; Karen L Kotloff; Timothy L Wyant; James P Nataro; Robert Edelman; J Perry; P Bedford; David M Brown; Steven N Chatfield; Gordon Dougan; Myron M Levine
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers.
Infection and immunity 2000;68(3):1196-201.
2000: Karen L Kotloff; FR Noriega; T Samandari; Marcelo B Sztein; Genevieve A Losonsky; James P Nataro; William D Picking; Eileen M Barry; Myron M Levine
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.
Infection and immunity 2000;68(3):1034-9.
2000: T Samandari; Karen L Kotloff; Genevieve A Losonsky; William D Picking; P J Sansonetti; Myron M Levine; Marcelo B Sztein
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(4):2221-32.
2000: TE Pickett; Marcela F Pasetti; James E Galen; Marcelo B Sztein; Myron M Levine
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.
Infection and immunity 2000;68(1):205-13.
1999: Orin S Levine; Rosanna Lagos; A Muñoz; J Villaroel; A M Alvarez; P Abrego; Myron M Levine
Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b.
The Pediatric infectious disease journal 1999;18(12):1060-4.
1999: James E Galen; J Nair; Jin Yuan Wang; Steven Wasserman; MK Tanner; Marcelo B Sztein; Myron M Levine
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.
Infection and immunity 1999;67(12):6424-33.
1999: Carol O Tacket; Mitchell B Cohen; Steven Wasserman; Genevieve A Losonsky; Sofie Livio; Karen L Kotloff; Robert Edelman; James B Kaper; Stanley J Cryz; Ralph A Giannella; Gilbert Schiff; Myron M Levine
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Infection and immunity 1999;67(12):6341-5.
1999: David N Taylor; Myron M Levine; L Kuppens; B Ivanoff
Why are typhoid vaccines not recommended for epidemic typhoid fever?
The Journal of infectious diseases 1999;180(6):2089-90.
1999: Rosanna Lagos; Alessio Fasano; Steven Wasserman; Valeria Prado; Oriana San Martin; P Abrego; Genevieve A Losonsky; S Alegria; Myron M Levine
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 1999;180(5):1709-12.
1999: Myron M Levine; C Ferreccio; paulina abrego; O S Martin; E Ortiz; Stanley J Cryz
Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.
Vaccine 1999;17 Suppl 2():S22-7.
1999: Georges Peter; M des Vignes-Kendrick; Theodore C Eickhoff; A Fine; V Galvin; Myron M Levine; Yvonne Maldonado; E K Marcuse; T P Monath; J E Osborn; S Plotkin; Gregory A Poland; M Patricia Quinlisk; D R Smith; M Sokol; D B Soland; Patricia N Whitley-Williams; Donald E Williamson; R F Breiman
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.
Pediatrics 1999;104(4 Pt 1):942-50.
1999: R Lagos; L F Avendaño; Myron M Levine
[Systematic surveillance of influenza, syncytial respiratory, parainfluenza and adenovirus in children with acute respiratory infections].
Revista médica de Chile 1999;127(9):1063-72.
1999: N Orr; James E Galen; Myron M Levine
Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.
Infection and immunity 1999;67(8):4290-4.
1999: Rosanna Lagos; Oriana San Martin; Steven Wasserman; Valeria Prado; Genevieve A Losonsky; C Bustamante; Myron M Levine
Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers.
The Pediatric infectious disease journal 1999;18(7):624-30.
1999: Marcela F Pasetti; RJ Anderson; FR Noriega; Myron M Levine; Marcelo B Sztein
Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses.
Clinical immunology (Orlando, Fla.) 1999;92(1):76-89.
1999: J Clemens; S Hoffman; B Ivanoff; keith klugman; Myron M Levine; M Neira; T Pang
Typhoid fever vaccines.
Vaccine 1999;17(20-21):2476-8.
1999: Valeria Prado; Rosanna Lagos; James P Nataro; Oriana San Martin; Carolina Arellano; J Y Wang; A A Borczyk; Myron M Levine
Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile.
The Pediatric infectious disease journal 1999;18(6):500-5.
1999: David N Taylor; J L Sanchez; J M Castro; Carlos LeBron; C M Parrado; D E Johnson; Carol O Tacket; Genevieve A Losonsky; Steven Wasserman; Myron M Levine; Stanley J Cryz
Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.
Infection and immunity 1999;67(4):2030-4.
1999: Myron M Levine; D Cohen; M Green; Orin S Levine; E D Mintz
Fly control and shigellosis.
Lancet 1999;353(9157):1020.
1999: M Rios; Valeria Prado; Michele Trucksis; Carolina Arellano; CF Borie; Marcela Alexandre; Alberto Fica; Myron M Levine
Clonal diversity of Chilean isolates of enterohemorrhagic Escherichia coli from patients with hemolytic-uremic syndrome, asymptomatic subjects, animal reservoirs, and food products.
Journal of clinical microbiology 1999;37(3):778-81.
1999: FR Noriega; F M Liao; D R Maneval; S Ren; S B Formal; Myron M Levine
Strategy for cross-protection among Shigella flexneri serotypes.
Infection and immunity 1999;67(2):782-8.
1999: Karen L Kotloff; J P Winickoff; B Ivanoff; John D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; Myron M Levine
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
Bulletin of the World Health Organization 1999;77(8):651-66.
1999: Myron M Levine; James W Curran
HIV vaccines and prevention in a world without Mary Lou Clements-Mann and Jonathan Mann.
Journal of human virology 1999;2(1):58-60.
1999: C Tang; Richard Moxon; Myron M Levine
For discussion: live attenuated vaccines for group B meningococcus.
Vaccine 1999;17(2):114-7.
1998: Valeria Prado; P Pidal; Carolina Arellano; Rosanna Lagos; Oriana San Martin; Myron M Levine
[Antimicrobial multiresistance of Shigella sp strains in a semi rural community of northern Santiago].
Revista médica de Chile 1998;126(12):1464-71.
1998: Rosanna Lagos; Orin S Levine; A Avendaño; I Horwitz; Myron M Levine
The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries.
The Pediatric infectious disease journal 1998;17(9 Suppl):S139-48.
1998: Rosanna Lagos; María Teresa Valenzuela; Orin S Levine; Genevieve A Losonsky; A Erazo; Steven Wasserman; Myron M Levine
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
Lancet 1998;351(9114):1472-6.
1998: Myron M Levine; G Dougan
Optimism over vaccines administered via mucosal surfaces.
Lancet 1998;351(9113):1375-6.
1998: C R González; FR Noriega; S Huerta; A Santiago; M Vega; J Paniagua; Vianney Ortiz-Navarrete; armando isibasi; Myron M Levine
Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.
Vaccine 1998;16(9-10):1043-52.
1998: Karel Hoppenbrouwers; R Lagos; B Swennen; C Ethevenaux; J Knops; Myron M Levine; J Desmyter
Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile.
Vaccine 1998;16(9-10):921-7.
1998: Carol O Tacket; Hugh S Mason; Genevieve A Losonsky; John Clements; Myron M Levine; Charles J Arntzen
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.
Nature medicine 1998;4(5):607-9.
1998: David A Sack; Carol O Tacket; Mitchell B Cohen; RICHARD SACK; Genevieve A Losonsky; Janet Shimko; James P Nataro; Robert Edelman; Myron M Levine; Ralph A Giannella; Gilbert Schiff; Dennis Lang
Validation of a volunteer model of cholera with frozen bacteria as the challenge.
Infection and immunity 1998;66(5):1968-72.
1998: Tikki Pang; Myron M Levine; B Ivanoff; J Wain; B B Finlay
Typhoid fever--important issues still remain.
Trends in microbiology 1998;6(4):131-3.
1998: Rosanna Lagos; Karen L Kotloff; Agnès Hoffenbach; Oriana San Martin; P Abrego; A M Ureta; E Pines; C Blondeau; F Bailleux; Myron M Levine
Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
The Pediatric infectious disease journal 1998;17(4):294-304.
1998: Myron M Levine; Rosanna Lagos; Orin S Levine; I Heitmann; N Enriquez; M E Pinto; A M Alvarez; E Wu; C Mayorga; A Reyes
Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country.
The Pediatric infectious disease journal 1998;17(4):287-93.
1998: Carol O Tacket; R K Taylor; Genevieve A Losonsky; Y Lim; James P Nataro; James B Kaper; Myron M Levine
Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection.
Infection and immunity 1998;66(2):692-5.
1998: R Ramakrishnan; David J Fink; Myron M Levine
Analysis of HSV-DNA and RNA Using the Polymerase Chain Reaction.
Methods in molecular medicine 1998;10():355-67.
1998: Myron M Levine
Experimental challenge studies in the development of vaccines for infectious diseases.
Developments in biological standardization 1998;95():169-74.
1998: R T Perry; Christopher Plowe; B Koumaré; F Bougoudogo; Karen L Kotloff; Genevieve A Losonsky; Steven Wasserman; Myron M Levine
A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.
Bulletin of the World Health Organization 1998;76(1):63-71.
1998: Michael S Donnenberg; Carol O Tacket; Genevieve A Losonsky; Gad Frankel; James P Nataro; Gordon Dougan; Myron M Levine
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.
Infection and immunity 1998;66(1):52-8.
1997: Myron M Levine; Orin S Levine
Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.
Lancet 1997;350(9088):1386-92.
1997: David N Taylor; Carol O Tacket; Genevieve A Losonsky; O Castro; J Gutierrez; Rina Meza; James P Nataro; James B Kaper; Steven Wasserman; Robert Edelman; Myron M Levine; Stanley J Cryz
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
Infection and immunity 1997;65(9):3852-6.
1997: Carol O Tacket; S M Kelly; F Schödel; Genevieve A Losonsky; James P Nataro; Robert Edelman; Myron M Levine; Roy Curtis
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
Infection and immunity 1997;65(8):3381-5.
1997: Carol O Tacket; Karen L Kotloff; Genevieve A Losonsky; James P Nataro; Jane Michalski; James B Kaper; Robert Edelman; Myron M Levine
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111.
The American journal of tropical medicine and hygiene 1997;56(5):533-7.
1997: Genevieve A Losonsky; Y Lim; P Motamedi; L E Comstock; Judith A Johnson; J Glenn Morris; Carol O Tacket; James B Kaper; Myron M Levine
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
Clinical and diagnostic laboratory immunology 1997;4(3):264-9.
1997: James E Galen; OG Gómez-Duarte; Genevieve A Losonsky; J L Halpern; C S Lauderbaugh; S Kaintuck; M K Reymann; Myron M Levine
A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
Vaccine 1997;15(6-7):700-8.
1997: Alessio Fasano; FR Noriega; F M Liao; W Wang; Myron M Levine
Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.
Gut 1997;40(4):505-11.
1997: Valeria Prado; J Martínez; Carolina Arellano; Myron M Levine
[Temporal variation of genotypes and serotypes of enterohemorrhagic E Coli isolated from Chilean children with intestinal infections or hemolytic uremic syndrome].
Revista médica de Chile 1997;125(3):291-7.
1997: Myron M Levine; James E Galen; Eileen M Barry; FR Noriega; Carol O Tacket; Marcelo B Sztein; Steven N Chatfield; Gordon Dougan; Genevieve A Losonsky; Karen L Kotloff
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Behring Institute Mitteilungen 1997;(98):120-3.
1997: Orin S Levine; DM Granoff; Rosanna Lagos; B Fritzell; Myron M Levine
Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age.
Vaccine 1997;15(3):325-8.
1997: S T Cookson; Daniel Stamboulian; J Demonte; L Quero; C Martinez de Arquiza; A Aleman; Alejandro Lepetic; Myron M Levine
A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
International journal of epidemiology 1997;26(1):212-9.
1997: Carol O Tacket; Marcelo B Sztein; Genevieve A Losonsky; Steven Wasserman; James P Nataro; Robert Edelman; Derek Pickard; Gordon Dougan; Steven N Chatfield; Myron M Levine
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
Infection and immunity 1997;65(2):452-6.
1997: Myron M Levine
Oral vaccines against cholera: lessons from Vietnam and elsewhere.
Lancet 1997;349(9047):220-1.
1996: Orin S Levine; R Lagos; Genevieve A Losonsky; Oriana San Martin; P Abrego; C Bustamante; Steven Wasserman; Myron M Levine
No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe.
The Journal of infectious diseases 1996;174(6):1341-4.
1996: Karen L Kotloff; FR Noriega; Genevieve A Losonsky; Marcelo B Sztein; Steven Wasserman; James P Nataro; Myron M Levine
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
Infection and immunity 1996;64(11):4542-8.
1996: Eileen M Barry; OG Gómez-Duarte; Steven N Chatfield; R Rappuoli; Mariagrazia Pizza; Genevieve A Losonsky; James E Galen; Myron M Levine
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
Infection and immunity 1996;64(10):4172-81.
1996: O Makarova; G Gorneva; F Wu; V Farutin; B Villeponteau; L Poliani; David J Fink; Myron M Levine
Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.
Gene therapy 1996;3(9):829-33.
1996: J P Cegielski; A E Msengi; C S Dukes; Myron M Levine
Pathogenic Escherichia coli in children with and without chronic diarrhea in Tanzania.
The Journal of infectious diseases 1996;174(3):675-7.
1996: R Ramakrishnan; PL Poliani; Myron M Levine; Joseph C Glorioso; David J Fink
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR.
Journal of virology 1996;70(9):6519-23.
1996: FR Noriega; Genevieve A Losonsky; C Lauderbaugh; F M Liao; J Y Wang; Myron M Levine
Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
Infection and immunity 1996;64(8):3055-61.
1996: Myron M Levine
The legacy of Edward Jenner.
BMJ (Clinical research ed.) 1996;312(7040):1177-8.
1996: Stephen J Savarino; A McVeigh; J Watson; A Cravioto; J Molina; P Echeverria; M K Bhan; Myron M Levine; Alessio Fasano
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli.
The Journal of infectious diseases 1996;173(4):1019-22.
1996: R Lagos; I Horwitz; J Toro; Oriana San Martin; P Abrego; C Bustamante; Steven Wasserman; Orin S Levine; Myron M Levine
Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections.
The Pediatric infectious disease journal 1996;15(3):216-22.
1996: Myron M Levine; James E Galen; Eileen M Barry; FR Noriega; Steven N Chatfield; Marcelo B Sztein; Gordon Dougan; Carol O Tacket
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
Journal of biotechnology 1996;44(1-3):193-6.
1996: David W K Acheson; Myron M Levine; James B Kaper; Gerald T Keusch
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.
Infection and immunity 1996;64(1):355-7.
1996: FR Noriega; Genevieve A Losonsky; J Y Wang; S B Formal; Myron M Levine
Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Infection and immunity 1996;64(1):23-7.
1996: Genevieve A Losonsky; J Yunyongying; V Lim; M Reymann; Y L Lim; Steven Wasserman; Myron M Levine
Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.
Infection and immunity 1996;64(1):10-5.
1995: Myron M Levine; FR Noriega
A review of the current status of enteric vaccines.
Papua and New Guinea medical journal 1995;38(4):325-31.
1995: Shaoguang Wu; David W Pascual; John L VanCott; Jerry R McGhee; D R Maneval; Myron M Levine; David Hone
Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.
Infection and immunity 1995;63(12):4933-8.
1995: James P Nataro; J Seriwatana; Alessio Fasano; D R Maneval; L D Guers; FR Noriega; Filip Dubovsky; Myron M Levine; J Glenn Morris
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains.
Infection and immunity 1995;63(12):4721-8.
1995: OG Gómez-Duarte; James E Galen; Steven N Chatfield; R Rappuoli; L Eidels; Myron M Levine
Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.
Vaccine 1995;13(16):1596-602.
1995: Karen L Kotloff; James P Nataro; Genevieve A Losonsky; Steven Wasserman; T L Hale; David N Taylor; J C Sadoff; Myron M Levine
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.
Vaccine 1995;13(16):1488-94.
1995: FR Noriega; F M Liao; S B Formal; Alessio Fasano; Myron M Levine
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes.
The Journal of infectious diseases 1995;172(5):1408-10.
1995: Marcelo B Sztein; MK Tanner; Y Polotsky; J M Orenstein; Myron M Levine
Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(8):3987-93.
1995: Jorge A. Giron; G I Viboud; Vanessa Sperandio; OG Gómez-Duarte; D R Maneval; M J Albert; Myron M Levine; James B Kaper
Prevalence and association of the longus pilus structural gene (lngA) with colonization factor antigens, enterotoxin types, and serotypes of enterotoxigenic Escherichia coli.
Infection and immunity 1995;63(10):4195-8.
1995: Valeria Prado; W Basualdo; Carolina Arellano; J Martínez; Myron M Levine
[In vitro susceptibility of enterohemorrhagic Escherichia coli to 11 antimicrobials. Relationship between antibiotic resistance and toxigenic genotype].
Revista médica de Chile 1995;123(9):1085-90.
1995: Carol O Tacket; Genevieve A Losonsky; James P Nataro; L Comstock; Jane Michalski; Robert Edelman; James B Kaper; Myron M Levine
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.
The Journal of infectious diseases 1995;172(3):883-6.
1995: Judith R Glynn; R B Hornick; Myron M Levine; David J Bradley
Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used.
Epidemiology and infection 1995;115(1):23-30.
1995: A Ojeda; Valeria Prado; J Martinez; Carolina Arellano; A Borczyk; W Johnson; H Lior; Myron M Levine
Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources.
Journal of clinical microbiology 1995;33(8):2199-201.
1995: Jorge A. Giron; J G Xu; C R González; David Hone; James B Kaper; Myron M Levine
Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908.
Vaccine 1995;13(10):939-46.
1995: Alessio Fasano; FR Noriega; D R Maneval; S Chanasongcram; R Russell; S Guandalini; Myron M Levine
Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.
The Journal of clinical investigation 1995;95(6):2853-61.
1995: Stanley J Cryz; John U Que; Myron M Levine; Gerhard Wiedermann; Herwig Kollaritsch
Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
Infection and immunity 1995;63(4):1336-9.
1995: Karen L Kotloff; Genevieve A Losonsky; James P Nataro; Steven Wasserman; T L Hale; David N Taylor; J W Newland; J C Sadoff; S B Formal; Myron M Levine
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Vaccine 1995;13(5):495-502.
1995: James P Nataro; Y Deng; S Cookson; A Cravioto; Stephen J Savarino; L D Guers; Myron M Levine; Carol O Tacket
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers.
The Journal of infectious diseases 1995;171(2):465-8.
1995: R Lagos; A Avendaño; V Prado; I Horwitz; S Wasserman; Genevieve A Losonsky; Stanley J Cryz; James B Kaper; Myron M Levine
Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
Infection and immunity 1995;63(2):707-9.
1995: Myron M Levine
Non-target effects of live vaccines: myth, reality and demagoguery.
Developments in biological standardization 1995;84():33-8.
1995: Stanley J Cryz; James B Kaper; Carol O Tacket; James P Nataro; Myron M Levine
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.
Developments in biological standardization 1995;84():237-44.
1995: Carol O Tacket; Genevieve A Losonsky; James P Nataro; Steven Wasserman; Stanley J Cryz; Robert Edelman; Myron M Levine
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(1):75-7.
1995: James B Kaper; J Glenn Morris; Myron M Levine
Cholera.
Clinical microbiology reviews 1995;8(1):48-86.
1995: L E Comstock; D Maneval; Pinaki Panigrahi; A Joseph; Myron M Levine; James B Kaper; J Glenn Morris; Judith A Johnson
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.
Infection and immunity 1995;63(1):317-23.
1994: Marcelo B Sztein; Steven Wasserman; Carol O Tacket; Robert Edelman; David Hone; A A Lindberg; Myron M Levine
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.
The Journal of infectious diseases 1994;170(6):1508-17.
1994: R Ramakrishnan; Myron M Levine; David J Fink
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
Journal of virology 1994;68(11):7083-91.
1994: FR Noriega; J Y Wang; Genevieve A Losonsky; D R Maneval; David Hone; Myron M Levine
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
Infection and immunity 1994;62(11):5168-72.
1994: Derek Pickard; J Li; Mark Roberts; Duncan J Maskell; David Hone; Myron M Levine; Gordon Dougan; Steven N Chatfield
Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression.
Infection and immunity 1994;62(9):3984-93.
1994: E C Medina; Göran Widmalm; A Weintraub; P A Vial; Myron M Levine; A A Lindberg
Structural studies of the O-antigenic polysaccharides of Escherichia coli O3 and the enteroaggregative Escherichia coli strain 17-2.
European journal of biochemistry / FEBS 1994;224(1):191-6.
1994: Steven Wasserman; Genevieve A Losonsky; FR Noriega; Carol O Tacket; E Castañeda; Myron M Levine
Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
Vaccine 1994;12(11):1000-3.
1994: David Hone; A M Harris; Myron M Levine
Adaptive acid tolerance response by Salmonella typhi and candidate live oral typhoid vaccine strains.
Vaccine 1994;12(10):895-8.
1994: David Hone; A M Harris; V Lim; Myron M Levine
Construction and characterization of isogenic O-antigen variants of Salmonella typhi.
Molecular microbiology 1994;13(3):525-30.
1994: William F Goins; L R Sternberg; K D Croen; P R Krause; R L Hendricks; David J Fink; Stephen E Straus; Myron M Levine; Joseph C Glorioso
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Journal of virology 1994;68(4):2239-52.
1994: C Gonzalez; David Hone; FR Noriega; Carol O Tacket; J R Davis; Genevieve A Losonsky; James P Nataro; S Hoffman; A Malik; Elizabeth H Nardin; Marcelo B Sztein; D G Heppner; T R Fouts; A Isibasi; Myron M Levine
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.
The Journal of infectious diseases 1994;169(4):927-31.
1994: James B Kaper; Jane Michalski; J M Ketley; Myron M Levine
Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR.
Infection and immunity 1994;62(4):1480-3.
1994: Jorge A. Giron; Myron M Levine; James B Kaper
Longus: a long pilus ultrastructure produced by human enterotoxigenic Escherichia coli.
Molecular microbiology 1994;12(1):71-82.
1994: Myron M Levine; Orin S Levine
Changes in human ecology and behavior in relation to the emergence of diarrheal diseases, including cholera.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2390-4.
1994: R Ramakrishnan; David J Fink; G Jiang; Prashant Desai; Joseph C Glorioso; Myron M Levine
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.
Journal of virology 1994;68(3):1864-73.
1994: Roy Curtis; S M Kelly; S A Tinge; Carol O Tacket; Myron M Levine; J Srinivasan; M Koopman
Recombinant Salmonella vectors in vaccine development.
Developments in biological standardization 1994;82():23-33.
1994: B Ivanoff; Myron M Levine; Paul-Henri Lambert
Vaccination against typhoid fever: present status.
Bulletin of the World Health Organization 1994;72(6):957-71.
1993: Steven Wasserman; Karen L Kotloff; Genevieve A Losonsky; Myron M Levine
Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect.
American journal of epidemiology 1993;138(11):988-93.
1993: Carol O Tacket; Genevieve A Losonsky; James P Nataro; Stanley J Cryz; Robert Edelman; Alessio Fasano; Jane Michalski; James B Kaper; Myron M Levine
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
The Journal of infectious diseases 1993;168(6):1536-40.
1993: Myron M Levine; FR Noriega
Vaccines to prevent bacterial enteric infections in children.
Pediatric annals 1993;22(12):719-25.
1993: Myron M Levine; C Ferreccio; Valeria Prado; M Cayazzo; P Abrego; J Martinez; L Maggi; M M Baldini; W Martin; D Maneval
Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile.
American journal of epidemiology 1993;138(10):849-69.
1993: Prashant Desai; R Ramakrishnan; Z W Lin; B Osak; Joseph C Glorioso; Myron M Levine
The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.
Journal of virology 1993;67(10):6125-35.
1993: Michael S Donnenberg; Carol O Tacket; Stephen P James; Genevieve A Losonsky; James P Nataro; Steven Wasserman; James B Kaper; Myron M Levine
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
The Journal of clinical investigation 1993;92(3):1412-7.
1993: A Avendano; C Ferreccio; R Lagos; I Horwitz; M Cayazzo; B Fritzell; C Meschievitz; Myron M Levine
Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
The Pediatric infectious disease journal 1993;12(8):638-43.
1993: W T Mahle; Myron M Levine
Salmonella typhi infection in children younger than five years of age.
The Pediatric infectious disease journal 1993;12(8):627-31.
1993: J M Ketley; Jane Michalski; James E Galen; Myron M Levine; James B Kaper
Construction of genetically marked Vibrio cholerae O1 vaccine strains.
FEMS microbiology letters 1993;111(1):15-21.
1993: Philip A Mackowiak; Steven Wasserman; Myron M Levine
Relationship between humoral immune responses and oral temperature during human shigellosis.
The Journal of infectious diseases 1993;167(6):1449-52.
1993: Myron M Levine; FR Noriega
Vaccines to prevent enteric infections.
Baillière's clinical gastroenterology 1993;7(2):501-17.
1993: S Pongsunk; Suttipant Sarasombath; P Ekpo; P Tangtherawattana; Myron M Levine
Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 1993;11(1):53-6.
1993: A Weintraub; K Leontein; Göran Widmalm; P A Vial; Myron M Levine; A A Lindberg
Structural studies of the O-antigenic polysaccharide of an enteroaggregative Escherichia coli strain.
European journal of biochemistry / FEBS 1993;213(2):859-64.
1993: Marcia K Wolf; David N Taylor; Edgar C Boedeker; K C Hyams; D R Maneval; Myron M Levine; K Tamura; R A Wilson; P Echeverria
Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East.
Journal of clinical microbiology 1993;31(4):851-6.
1993: Stephen J Savarino; Alessio Fasano; J Watson; B M Martin; Myron M Levine; S Guandalini; Patricia Guerry
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(7):3093-7.
1993: Philip J Gage; Myron M Levine; Joseph C Glorioso
Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B.
Journal of virology 1993;67(4):2191-201.
1993: Stanley J Cryz; N Vanprapar; U Thisyakorn; T Olanratmanee; Genevieve A Losonsky; Myron M Levine; S Chearskul
Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.
Infection and immunity 1993;61(3):1149-51.
1993: M B Cohen; J A Hawkins; L S Weckbach; J L Staneck; Myron M Levine; J E Heck
Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea.
Journal of clinical microbiology 1993;31(2):351-3.
1993: Genevieve A Losonsky; Carol O Tacket; Steven Wasserman; James B Kaper; Myron M Levine
Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
Infection and immunity 1993;61(2):729-33.
1993: Myron M Levine; James B Kaper
Live oral vaccines against cholera: an update.
Vaccine 1993;11(2):207-12.
1993: Robert Edelman; R G Russell; Genevieve A Losonsky; BD Tall; Carol O Tacket; Myron M Levine; D H Lewis
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).
Vaccine 1993;11(2):155-8.
1992: S Tzipori; J Montanaro; Roy M Robins-Browne; P Vial; R Gibson; Myron M Levine
Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model.
Infection and immunity 1992;60(12):5302-6.
1992: Philip A Mackowiak; Steven Wasserman; Myron M Levine
An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis.
The Journal of infectious diseases 1992;166(5):1181-4.
1992: Carol O Tacket; Genevieve A Losonsky; James P Nataro; Stanley J Cryz; Robert Edelman; James B Kaper; Myron M Levine
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 1992;166(4):837-41.
1992: Karen L Kotloff; Steven Wasserman; S O'Donnell; Genevieve A Losonsky; Stanley J Cryz; Myron M Levine
Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial.
Infection and immunity 1992;60(10):4430-2.
1992: Philip A Mackowiak; Steven Wasserman; Myron M Levine
A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich.
JAMA : the journal of the American Medical Association 1992;268(12):1578-80.
1992: M J Finch; Augusto A. Franco-Mora; Eduardo Gotuzzo; C Carrillo; L Benavente; Steven Wasserman; Myron M Levine; J Glenn Morris
Plasmids in Salmonella typhi in Lima, Peru, 1987-1988: epidemiology and lack of association with severity of illness or clinical complications.
The American journal of tropical medicine and hygiene 1992;47(3):390-6.
1992: Stanley J Cryz; Myron M Levine; Genevieve A Losonsky; James B Kaper; B Althaus
Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.
Infection and immunity 1992;60(9):3916-7.
1992: Philip J Gage; B Sauer; Myron M Levine; Joseph C Glorioso
A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome.
Journal of virology 1992;66(9):5509-15.
1992: R Harpaz; Robert Edelman; Steven Wasserman; Myron M Levine; J R Davis; Marcelo B Sztein
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.
The Journal of clinical investigation 1992;90(2):515-23.
1992: David Hone; Carol O Tacket; A M Harris; B Kay; Genevieve A Losonsky; Myron M Levine
Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.
The Journal of clinical investigation 1992;90(2):412-20.
1992: T Olanratmanee; Myron M Levine; Genevieve A Losonsky; V Thisyakorn; Stanley J Cryz
Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.
The Journal of infectious diseases 1992;166(2):451-2.
1992: J Glenn Morris; Carol O Tacket; Myron M Levine
Oral carrier vaccines: new tricks in an old trade.
Gastroenterology 1992;103(2):699-702.
1992: Augusto A. Franco-Mora; C Gonzalez; Orin S Levine; R Lagos; R H Hall; Stephen L Hoffman; M A Moechtar; E Gotuzzo; Myron M Levine; David Hone
Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru.
Journal of clinical microbiology 1992;30(8):2187-90.
1992: A Cordovéz; Valeria Prado; L Maggi; J Cordero; J Martinez; A Misraji; R Rios; G Soza; A Ojeda; Myron M Levine
Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.
Journal of clinical microbiology 1992;30(8):2153-7.
1992: K E Dolter; William F Goins; Myron M Levine; Joseph C Glorioso
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.
Journal of virology 1992;66(8):4864-73.
1992: Myron M Levine; J McEwen; Genevieve A Losonsky; M Reymann; I Harari; John Brown; David N Taylor; Arthur Donohue-Rolfe; D Cohen; Michael Bennish
Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
Journal of clinical microbiology 1992;30(7):1636-41.
1992: L L Van de Verg; D A Herrington; J Boslego; A A Lindberg; Myron M Levine
Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations.
The Journal of infectious diseases 1992;166(1):158-61.
1992: Karen L Kotloff; John E Herrmann; NR Blacklow; R W Hudson; Steven Wasserman; J Glenn Morris; Myron M Levine
The frequency of astrovirus as a cause of diarrhea in Baltimore children.
The Pediatric infectious disease journal 1992;11(7):587-9.
1992: Karen L Kotloff; D A Herrington; T L Hale; J W Newland; L Van De Verg; J P Cogan; P J Snoy; J C Sadoff; S B Formal; Myron M Levine
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.
Infection and immunity 1992;60(6):2218-24.
1992: James P Nataro; Y Deng; D R Maneval; A L German; W C Martin; Myron M Levine
Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes.
Infection and immunity 1992;60(6):2297-304.
1992: J R Davis; Joseph F Cortese; D A Herrington; J R Murphy; D F Clyde; Alan Thomas; S Baqar; M A Cochran; J Thanassi; Myron M Levine
Plasmodium falciparum: in vitro characterization and human infectivity of a cloned line.
Experimental parasitology 1992;74(2):159-68.
1992: J D Clemens; C Ferreccio; Myron M Levine; I Horwitz; Malla Rao; Kathryn M Edwards; B Fritzell
Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
JAMA : the journal of the American Medical Association 1992;267(5):673-8.
1992: Carol O Tacket; David Hone; Roy Curtis; S M Kelly; Genevieve A Losonsky; L Guers; A M Harris; Robert Edelman; Myron M Levine
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.
Infection and immunity 1992;60(2):536-41.
1992: R Contreras; C Ferreccio; V Sotomayor; L Astroza; G Berríos; E Ortiz; C Palomino; I Prenzel; M E Pinto; Myron M Levine
[Typhoid fever in school children: by what measures is the modification of the clinical course due to oral vaccination?].
Revista médica de Chile 1992;120(2):134-41.
1992: P Echeverria; O Serichantalerg; S Changchawalit; B Baudry; Myron M Levine; F Orskov; I Orskov
Tissue culture-adherent Escherichia coli in infantile diarrhea.
The Journal of infectious diseases 1992;165(1):141-3.
1992: Carol O Tacket; David Hone; Genevieve A Losonsky; L Guers; Robert Edelman; Myron M Levine
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.
Vaccine 1992;10(7):443-6.
1992: Carol O Tacket; Genevieve A Losonsky; M D Lubeck; A R Davis; S Mizutani; G Horwith; P Hung; Robert Edelman; Myron M Levine
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
Vaccine 1992;10(10):673-6.
1992: D A Herrington; Genevieve A Losonsky; G Smith; F Volvovitz; M Cochran; K Jackson; Stephen L Hoffman; Daniel M Gordon; Myron M Levine; Robert Edelman
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
Vaccine 1992;10(12):841-6.
1992: Steven N Chatfield; Neil Fairweather; Ian G Charles; Derek Pickard; Myron M Levine; David Hone; M Posada; R A Strugnell; Gordon Dougan
Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.
Vaccine 1992;10(1):53-60.
1991: R Lagos; A Avendano; I Horwitz; J M Musser; S K Hoiseth; D R Maneval; M J Jones; Myron M Levine; J P Dattas; I Prenzel
Molecular epidemiology of Haemophilus influenzae within families in Santiago, Chile.
The Journal of infectious diseases 1991;164(6):1149-53.
1991: D A Herrington; Elizabeth H Nardin; Genevieve A Losonsky; I C Bathurst; P J Barr; M R Hollingdale; Robert Edelman; Myron M Levine
Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.
The American journal of tropical medicine and hygiene 1991;45(6):695-701.
1991: J Glenn Morris; Valeria Prado; C Ferreccio; Roy M Robins-Browne; A M Bordun; M Cayazzo; B A Kay; Myron M Levine
Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors.
Journal of clinical microbiology 1991;29(12):2784-8.
1991: D Herrington; J Davis; Elizabeth H Nardin; M Beier; Joseph F Cortese; H Eddy; Genevieve A Losonsky; M Hollingdale; Marcelo B Sztein; Myron M Levine
Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
The American journal of tropical medicine and hygiene 1991;45(5):539-47.
1991: J R Murphy; L Grez; L Schlesinger; C Ferreccio; S Baqar; C Muñoz; Steven Wasserman; Genevieve A Losonsky; J G Olson; Myron M Levine
Immunogenicity of Salmonella typhi Ty21a vaccine for young children.
Infection and immunity 1991;59(11):4291-3.
1991: David Hone; A M Harris; Steven N Chatfield; Gordon Dougan; Myron M Levine
Construction of genetically defined double aro mutants of Salmonella typhi.
Vaccine 1991;9(11):810-6.
1991: C Ferreccio; J Clemens; A Avendano; I Horwitz; C Flores; L Avila; M Cayazzo; B Fritzell; M Cadoz; Myron M Levine
The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.
The Pediatric infectious disease journal 1991;10(10):764-71.
1991: C Ferreccio; Valeria Prado; A Ojeda; M Cayyazo; P Abrego; L Guers; Myron M Levine
Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile.
American journal of epidemiology 1991;134(6):614-27.
1991: S L Highlander; William F Goins; Stanley Person; Thomas C Holland; Myron M Levine; Joseph C Glorioso
Oligomer formation of the gB glycoprotein of herpes simplex virus type 1.
Journal of virology 1991;65(8):4275-83.
1991: Orin S Levine; Myron M Levine
Houseflies (Musca domestica) as mechanical vectors of shigellosis.
Reviews of infectious diseases 1991;13(4):688-96.
1991: R H Hall; Genevieve A Losonsky; A P Silveira; R K Taylor; J J Mekalanos; N D Witham; Myron M Levine
Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.
Infection and immunity 1991;59(7):2508-12.
1991: Dani Cohen; M Green; Colin Block; R Slepon; R Ambar; Steven Wasserman; Myron M Levine
Reduction of transmission of shigellosis by control of houseflies (Musca domestica)
Lancet 1991;337(8748):993-7.
1991: Carol O Tacket; Genevieve A Losonsky; David N Taylor; L S Baron; D Kopecko; Stanley J Cryz; Myron M Levine
Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
The Journal of infectious diseases 1991;163(4):901-4.
1991: Stephen J Savarino; Alessio Fasano; D C Robertson; Myron M Levine
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model.
The Journal of clinical investigation 1991;87(4):1450-5.
1991: Myron M Levine
Vaccines and milk immunoglobulin concentrates for prevention of infectious diarrhea.
The Journal of pediatrics 1991;118(4 Pt 2):S129-36.
1991: Robert Edelman; Myron M Levine
Enteric vaccines.
Maryland medical journal (Baltimore, Md. : 1985) 1991;40(3):199-203.
1991: S Servos; Steven N Chatfield; David Hone; Myron M Levine; G Dimitriadis; Derek Pickard; Gordon Dougan; Neil Fairweather; Ian G Charles
Molecular cloning and characterization of the aroD gene encoding 3-dehydroquinase from Salmonella typhi.
Journal of general microbiology 1991;137(1):147-52.
1990: Stanley J Cryz; Myron M Levine; James B Kaper; Emil Fürer; B Althaus
Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults.
Vaccine 1990;8(6):577-80.
1990: K G Gicquelais; M M Baldini; J Martinez; L Maggi; W C Martin; Valeria Prado; James B Kaper; Myron M Levine
Practical and economical method for using biotinylated DNA probes with bacterial colony blots to identify diarrhea-causing Escherichia coli.
Journal of clinical microbiology 1990;28(11):2485-90.
1990: Myron M Levine; C Ferreccio; Stanley J Cryz; E Ortiz
Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.
Lancet 1990;336(8720):891-4.
1990: James B Kaper; Myron M Levine
Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
Research in microbiology 1990;141(7-8):901-6.
1990: Myron M Levine; David Hone; Carol O Tacket; C Ferreccio; Stanley J Cryz
Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
Research in microbiology 1990;141(7-8):807-16.
1990: D A Herrington; L Van de Verg; S B Formal; T L Hale; BD Tall; Stanley J Cryz; E C Tramont; Myron M Levine
Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Vaccine 1990;8(4):353-7.
1990: Carol O Tacket; S L Moseley; B Kay; Genevieve A Losonsky; Myron M Levine
Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to HEp-2 cells.
The Journal of infectious diseases 1990;162(2):550-2.
1990: K A Kimmel; K E Dolter; G M Toth; Myron M Levine; Joseph C Glorioso
Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.
Journal of virology 1990;64(8):4033-6.
1990: C Ferreccio; E Ortiz; L Astroza; C Rivera; J Clemens; Myron M Levine
A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile.
The Pediatric infectious disease journal 1990;9(7):488-94.
1990: Theodore E Nash; D A Herrington; Myron M Levine; J T Conrad; J W Merritt
Antigenic variation of Giardia lamblia in experimental human infections.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4362-9.
1990: B Baudry; Stephen J Savarino; Pablo A Vial; James B Kaper; Myron M Levine
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen.
The Journal of infectious diseases 1990;161(6):1249-51.
1990: L Van de Verg; D A Herrington; J R Murphy; Steven Wasserman; S B Formal; Myron M Levine
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Infection and immunity 1990;58(6):2002-4.
1990: Carol O Tacket; B Forrest; Renato Morona; Stephen R Attridge; J LaBrooy; BD Tall; M Reymann; D Rowley; Myron M Levine
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
Infection and immunity 1990;58(6):1620-7.
1990: Margaret B Rennels; Genevieve A Losonsky; A E Young; C L Shindledecker; A Z Kapikian; Myron M Levine
An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
American journal of diseases of children (1960) 1990;144(5):601-4.
1990: J M Ketley; James B Kaper; D A Herrington; Genevieve A Losonsky; Myron M Levine
Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103.
Infection and immunity 1990;58(5):1481-4.
1990: P A Vial; J J Mathewson; H L DuPont; L Guers; Myron M Levine
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea.
Journal of clinical microbiology 1990;28(5):882-5.
1990: Myron M Levine
Modern vaccines. Enteric infections.
Lancet 1990;335(8695):958-61.
1990: Pablo A Vial; Karen L Kotloff; BD Tall; J Glenn Morris; Myron M Levine
Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children.
The Journal of infectious diseases 1990;161(3):571-3.
1990: Myron M Levine; Robert Edelman
Future vaccines against enteric pathogens.
Infectious disease clinics of North America 1990;4(1):105-21.
1990: Robert E Black; Myron M Levine; C Ferreccio; M L Clements; C Lanata; J Rooney; R Germanier
Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee.
Vaccine 1990;8(1):81-4.
1990: C T Wu; Myron M Levine; F Homa; S L Highlander; Joseph C Glorioso
Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.
Journal of virology 1990;64(2):856-63.
1990: P C Weber; Myron M Levine; Joseph C Glorioso
Recombinogenic properties of herpes simplex virus type 1 DNA sequences resident in simian virus 40 minichromosomes.
Journal of virology 1990;64(1):300-6.
1990: C Ferreccio; Myron M Levine; L Astroza; G Berrios; V Solari; A Misraji; C Pefaur
[The detection of chronic Salmonella typhi carriers: a practical method applied to food handlers].
Revista médica de Chile 1990;118(1):33-7.
1990: Elizabeth H Nardin; Ruth S Nussenzweig; R Altszuler; D Herrington; Myron M Levine; J Murphy; J Davis; I Bathurst; P Barr; P Romero
Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
Bulletin of the World Health Organization 1990;68 Suppl():85-7.
1990: Myron M Levine; A Krikos; Joseph C Glorioso; Fred Homa
Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1).
Advances in experimental medicine and biology 1990;278():151-64.
1989: Elizabeth H Nardin; D A Herrington; J Davis; Myron M Levine; D Stuber; B Takacs; P Caspers; P Barr; R Altszuler; P Clavijo
Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.
Science (New York, N.Y.) 1989;246(4937):1603-6.
1989: D Di John; Steven Wasserman; J R Torres; M J Cortesia; J Murillo; Genevieve A Losonsky; D A Herrington; D Stürcher; Myron M Levine
Effect of priming with carrier on response to conjugate vaccine.
Lancet 1989;2(8677):1415-8.
1989: J R Davis; J R Murphy; S Baqar; D F Clyde; D A Herrington; Myron M Levine
Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1989;83(6):748-50.
1989: R H Hall; D R Maneval; J H Collins; J L Theibert; Myron M Levine
Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli.
Journal of bacteriology 1989;171(11):6372-4.
1989: D P Sharma; C Thomas; R H Hall; Myron M Levine; Stephen R Attridge
Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
Vaccine 1989;7(5):451-6.
1989: T D Palella; Y Hidaka; L J Silverman; Myron M Levine; Joseph C Glorioso; W N Kelley
Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector.
Gene 1989;80(1):137-44.
1989: Karen L Kotloff; Genevieve A Losonsky; J Glenn Morris; Steven Wasserman; N Singh-Naz; Myron M Levine
Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings.
Pediatrics 1989;84(2):219-25.
1989: P C Weber; Myron M Levine; J C Glorioso
A rapid and sensitive method for plasmid copy number comparisons.
Nucleic acids research 1989;17(14):5866.
1989: Myron M Levine; David N Taylor; C Ferreccio
Typhoid vaccines come of age.
The Pediatric infectious disease journal 1989;8(6):374-81.
1989: H L DuPont; Myron M Levine; R B Hornick; S B Formal
Inoculum size in shigellosis and implications for expected mode of transmission.
The Journal of infectious diseases 1989;159(6):1126-8.
1989: Maharaj K Bhan; P Raj; Myron M Levine; James B Kaper; Nita Bhandari; R Srivastava; R Kumar; Sunil Sazawal
Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India.
The Journal of infectious diseases 1989;159(6):1061-4.
1989: Clarence Chrisp; J C Sunstrum; D R Averill; Myron M Levine; Joseph C Glorioso
Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
Laboratory investigation; a journal of technical methods and pathology 1989;60(6):822-30.
1989: Myron M Levine; C Ferreccio; Robert E Black; Carol O Tacket; R Germanier
Progress in vaccines against typhoid fever.
Reviews of infectious diseases 1989;11 Suppl 3():S552-67.
1989: C Ferreccio; Myron M Levine; H Rodriguez; R Contreras
Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.
The Journal of infectious diseases 1989;159(4):766-9.
1989: K Richardson; James B Kaper; Myron M Levine
Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.
Infection and immunity 1989;57(2):495-501.
1989: J R Murphy; Steven Wasserman; S Baqar; L Schlesinger; C Ferreccio; A A Lindberg; Myron M Levine
Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.
Clinical and experimental immunology 1989;75(2):228-33.
1989: S L Highlander; D J Dorney; Philip J Gage; Thomas C Holland; W Cai; Stanley Person; Myron M Levine; Joseph C Glorioso
Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration.
Journal of virology 1989;63(2):730-8.
1989: Maharaj K Bhan; N Bhandari; Sunil Sazawal; J Clemens; P Raj; Myron M Levine; James B Kaper
Descriptive epidemiology of persistent diarrhoea among young children in rural northern India.
Bulletin of the World Health Organization 1989;67(3):281-8.
1989: Y Hidaka; W N Kelley; Myron M Levine; Joseph C Glorioso; L J Silverman; T D Palella
Expression of human hypoxanthine guanine phosphoribosyltransferase mRNA in brains of mice infected with a recombinant herpes simplex virus type 1.
Transactions of the Association of American Physicians 1989;102():91-100.
1989: T D Palella; L J Silverman; Fred Homa; Myron M Levine; W N Kelley
Transfer of human HPRT gene sequences into neuronal cells by a herpes simplex virus derived vector.
Advances in experimental medicine and biology 1989;253A():549-54.
1989: Marcia K Wolf; G P Andrews; B D Tall; M M McConnell; Myron M Levine; Edgar C Boedeker
Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775.
Infection and immunity 1989;57(1):164-73.
1988: Karen L Kotloff; Steven Wasserman; J Y Steciak; BD Tall; Genevieve A Losonsky; Prasanna Nair; J Glenn Morris; Myron M Levine
Acute diarrhea in Baltimore children attending an outpatient clinic.
The Pediatric infectious disease journal 1988;7(11):753-9.
1988: M J Finch; J Glenn Morris; J Kaviti; W Kagwanja; Myron M Levine
Epidemiology of antimicrobial resistant cholera in Kenya and East Africa.
The American journal of tropical medicine and hygiene 1988;39(5):484-90.
1988: V Huff; W Cai; Joseph C Glorioso; Myron M Levine
The carboxy-terminal 41 amino acids of herpes simplex virus type 1 glycoprotein B are not essential for production of infectious virus particles.
Journal of virology 1988;62(11):4403-6.
1988: D A Herrington; R H Hall; Genevieve A Losonsky; J J Mekalanos; R K Taylor; Myron M Levine
Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.
The Journal of experimental medicine 1988;168(4):1487-92.
1988: P C Weber; Myron M Levine; Joseph C Glorioso
Simple assay for quantitation of Tn5 inversion events in Escherichia coli and use of the assay in determination of plasmid copy number.
Journal of bacteriology 1988;170(10):4972-5.
1988: C Ferreccio; G Berríos; Myron M Levine; J García; W Silva; H Rodríguez
[Typhoid fever in Santiago: the role of food handlers at elementary schools].
Revista médica de Chile 1988;116(9):952-6.
1988: Myron M Levine; James B Kaper; D Herrington; Genevieve A Losonsky; Carol O Tacket; BD Tall
The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):401-15.
1988: D Di John; Myron M Levine
Treatment of diarrhea.
Infectious disease clinics of North America 1988;2(3):719-45.
1988: Myron M Levine; Carol O Tacket; D Herrington; Genevieve A Losonsky; J Murphy; C Ferreccio
The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):459-69.
1988: Myron M Levine; D Herrington; D Clyde; J Murphy; J Davis; R Nussenzweig; Elizabeth H Nardin; A Felix; E Heimer; D Gillesen
Malaria vaccines: experience with sporozoite vaccines against falciparum malaria.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):369-74.
1988: Myron M Levine; James B Kaper; D Herrington; J Ketley; Genevieve A Losonsky; Carol O Tacket; BD Tall; Stanley J Cryz
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.
Lancet 1988;2(8609):467-70.
1988: Carol O Tacket; Myron M Levine; J B Robbins
Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
Vaccine 1988;6(4):307-8.
1988: J C Sunstrum; Clarence Chrisp; Myron M Levine; Joseph C Glorioso
Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.
Virus research 1988;11(1):17-32.
1988: P C Weber; M D Challberg; N J Nelson; Myron M Levine; Joseph C Glorioso
Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity.
Cell 1988;54(3):369-81.
1988: Myron M Levine; Valeria Prado; Roy M Robins-Browne; H Lior; James B Kaper; S L Moseley; K Gicquelais; James P Nataro; Pablo A Vial; BD Tall
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli.
The Journal of infectious diseases 1988;158(1):224-8.
1988: Pablo A Vial; Roy M Robins-Browne; H Lior; Valeria Prado; James B Kaper; James P Nataro; D Maneval; A Elsayed; Myron M Levine
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease.
The Journal of infectious diseases 1988;158(1):70-9.
1988: C Ferreccio; J Glenn Morris; C Valdivieso; I Prenzel; V Sotomayor; George L Drusano; Myron M Levine
Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.
The Journal of infectious diseases 1988;157(6):1235-9.
1988: Genevieve A Losonsky; Margaret B Rennels; Y Lim; G Krall; A Z Kapikian; Myron M Levine
Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.
The Pediatric infectious disease journal 1988;7(6):388-93.
1988: S L Highlander; W H Cai; Stanley Person; Myron M Levine; Joseph C Glorioso
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
Journal of virology 1988;62(6):1881-8.
1988: Carol O Tacket; Genevieve A Losonsky; H Link; Y Hoang; P Guesry; H Hilpert; Myron M Levine
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
The New England journal of medicine 1988;318(19):1240-3.
1988: D Pizarro; Myron M Levine; G Posada; L Sandi
Comparison of glucose/electrolyte and glucose/glycine/electrolyte oral rehydration solutions in hospitalized children with diarrhea in Costa Rica.
Journal of pediatric gastroenterology and nutrition 1988;7(3):411-6.
1988: Stanley J Cryz; E Fürer; Myron M Levine
[Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials].
Schweizerische medizinische Wochenschrift 1988;118(13):467-70.
1988: D A Herrington; D F Clyde; J R Murphy; S Baqar; Myron M Levine; V do Rosario; M R Hollingdale
A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.
Tropical and geographical medicine 1988;40(2):124-7.
1988: R H Hall; Pablo A Vial; James B Kaper; J J Mekalanos; Myron M Levine
Morphological studies on fimbriae expressed by Vibrio cholerae 01.
Microbial pathogenesis 1988;4(4):257-65.
1988: James B Kaper; Myron M Levine
Progress towards a vaccine against enterotoxigenic Escherichia coli.
Vaccine 1988;6(2):197-9.
1988: Robert E Black; Myron M Levine; M L Clements; T P Hughes; Martin Blaser
Experimental Campylobacter jejuni infection in humans.
The Journal of infectious diseases 1988;157(3):472-9.
1988: Myron M Levine; P Vial
Escherichia coli that cause diarrhea.
Indian journal of pediatrics 1988;55(2):183-90.
1988: Myron M Levine; C Ferreccio
Typhoid vaccines.
Lancet 1988;1(8578):173.
1988: Myron M Levine; James B Kaper; D Herrington; Genevieve A Losonsky; J Glenn Morris; M L Clements; Robert E Black; BD Tall; R Hall
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.
Infection and immunity 1988;56(1):161-7.
1988: Fred Homa; Joseph C Glorioso; Myron M Levine
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene.
Genes & development 1988;2(1):40-53.
1988: T D Palella; L J Silverman; C T Schroll; Fred Homa; Myron M Levine; W N Kelley
Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.
Molecular and cellular biology 1988;8(1):457-60.
1987: Theodore E Nash; D A Herrington; Genevieve A Losonsky; Myron M Levine
Experimental human infections with Giardia lamblia.
The Journal of infectious diseases 1987;156(6):974-84.
1987: J R Murphy; S Baqar; C Muñoz; L Schlesinger; C Ferreccio; A A Lindberg; stefan svenson; Genevieve A Losonsky; F Koster; Myron M Levine
Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.
The Journal of infectious diseases 1987;156(6):1005-9.
1987: Genevieve A Losonsky; C Ferreccio; Karen L Kotloff; S Kaintuck; J B Robbins; Myron M Levine
Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers.
Journal of clinical microbiology 1987;25(12):2266-9.
1987: S Tzipori; H Karch; K I Wachsmuth; Roy M Robins-Browne; A D O'Brien; H Lior; M L Cohen; J Smithers; Myron M Levine
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.
Infection and immunity 1987;55(12):3117-25.
1987: S L Highlander; S L Sutherland; Philip J Gage; David C Johnson; Myron M Levine; Joseph C Glorioso
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
Journal of virology 1987;61(11):3356-64.
1987: R D Shaw; K J Fong; Genevieve A Losonsky; Myron M Levine; Yvonne Maldonado; Robert H Yolken; J Flores; A Z Kapikian; P T Vo; Harry B Greenberg
Epitope-specific immune responses to rotavirus vaccination.
Gastroenterology 1987;93(5):941-50.
1987: James P Nataro; James B Kaper; Roy M Robins-Browne; Valeria Prado; Pablo A Vial; Myron M Levine
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells.
The Pediatric infectious disease journal 1987;6(9):829-31.
1987: A K Robbins; D J Dorney; M W Wathen; M E Whealy; C Gold; R J Watson; L E Holland; S D Weed; Myron M Levine; J C Glorioso
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus.
Journal of virology 1987;61(9):2691-701.
1987: Eduardo Gotuzzo; J Glenn Morris; L Benavente; P K Wood; Orin S Levine; Robert E Black; Myron M Levine
Association between specific plasmids and relapse in typhoid fever.
Journal of clinical microbiology 1987;25(9):1779-81.
1987: T E Nash; D A Herrington; Myron M Levine
Usefulness of an enzyme-linked immunosorbent assay for detection of Giardia antigen in feces.
Journal of clinical microbiology 1987;25(7):1169-71.
1987: Myron M Levine; J G Xu; James B Kaper; H Lior; V Prado; B Tall; James P Nataro; H Karch; K Wachsmuth
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome.
The Journal of infectious diseases 1987;156(1):175-82.
1987: Helge Karch; J Heesemann; Rainer Laufs; H P Kroll; James B Kaper; Myron M Levine
Serological response to type 1-like somatic fimbriae in diarrheal infection due to classical enteropathogenic Escherichia coli.
Microbial pathogenesis 1987;2(6):425-34.
1987: Robert E Black; Myron M Levine; M L Clements; Genevieve A Losonsky; D Herrington; S Berman; S B Formal
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
The Journal of infectious diseases 1987;155(6):1260-5.
1987: Myron M Levine; C Ferreccio; Robert E Black; R Germanier
Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.
Lancet 1987;1(8541):1049-52.
1987: Robert E Black; Myron M Levine; M L Clements; C R Young; A M Svennerholm; J Holmgren
Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
Infection and immunity 1987;55(5):1116-20.
1987: P C Weber; Myron M Levine; J C Glorioso
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.
Science (New York, N.Y.) 1987;236(4801):576-9.
1987: Carol O Tacket; D R Maneval; Myron M Levine
Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4.
Infection and immunity 1987;55(5):1063-9.
1987: M Shapira; Fred Homa; J C Glorioso; Myron M Levine
Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes.
Nucleic acids research 1987;15(7):3097-111.
1987: D A Herrington; S Tzipori; R M Robins-Browne; BD Tall; Myron M Levine
In vitro and in vivo pathogenicity of Plesiomonas shigelloides.
Infection and immunity 1987;55(4):979-85.
1987: Myron M Levine; D Herrington; J R Murphy; J Glenn Morris; Genevieve A Losonsky; BD Tall; A A Lindberg; stefan svenson; S Baqar; M F Edwards
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
The Journal of clinical investigation 1987;79(3):888-902.
1987: Myron M Levine
Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.
The Journal of infectious diseases 1987;155(3):377-89.
1987: Margaret B Rennels; Genevieve A Losonsky; C L Shindledecker; T P Hughes; A Z Kapikian; Myron M Levine
Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children.
The Pediatric infectious disease journal 1987;6(3):260-4.
1987: D T Pizarro; G S Posada; Myron M Levine; D R Nalin; E V Mohs
Comparison of efficacy of oral rehydration fluids administered at 37 degrees C or 23 degrees C.
Journal of tropical pediatrics 1987;33(1):48-51.
1987: H Karch; J Heesemann; R Laufs; A D O'Brien; Carol O Tacket; Myron M Levine
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells.
Infection and immunity 1987;55(2):455-61.
1987: G E Kikuchi; S A Baker; Sofia D Merajver; J E Coligan; Myron M Levine; Joseph C Glorioso; R Nairn
Purification and structural characterization of herpes simplex virus glycoprotein C.
Biochemistry 1987;26(2):424-31.
1987: Jan Holmgren; Ann-Mari Svennerholm; John Clemens; David A Sack; Robert E Black; Myron M Levine
An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial.
Advances in experimental medicine and biology 1987;216B():1649-60.
1987: Robert E Black; Myron M Levine; M L Clements; T Hughes; S O'Donnell
Association between O blood group and occurrence and severity of diarrhoea due to Escherichia coli.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1987;81(1):120-3.
1986: M R Thompson; R L Jordan; M A Luttrell; H Brandwein; James B Kaper; Myron M Levine; R A Giannella
Blinded, two-laboratory comparative analysis of Escherichia coli heat-stable enterotoxin production by using monoclonal antibody enzyme-linked immunosorbent assay, radioimmunoassay, suckling mouse assay, and gene probes.
Journal of clinical microbiology 1986;24(5):753-8.
1986: Fred Homa; T M Otal; J C Glorioso; Myron M Levine
Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA.
Molecular and cellular biology 1986;6(11):3652-66.
1986: Margaret B Rennels; Genevieve A Losonsky; Myron M Levine; A Z Kapikian
Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children.
Pediatric infectious disease 1986;5(5):587-8.
1986: Carol O Tacket; C Ferreccio; John B Robbins; C M Tsai; D Schulz; M Cadoz; A Goudeau; Myron M Levine
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
The Journal of infectious diseases 1986;154(2):342-5.
1986: K O Maher; J Glenn Morris; Eduardo Gotuzzo; C Ferreccio; L R Ward; L Benavente; Robert E Black; B Rowe; Myron M Levine
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing.
The American journal of tropical medicine and hygiene 1986;35(4):831-5.
1986: S D Marlin; S L Highlander; Thomas C Holland; Myron M Levine; Joseph C Glorioso
Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
Journal of virology 1986;59(1):142-53.
1986: Robert Edelman; Myron M Levine
Summary of an international workshop on typhoid fever.
Reviews of infectious diseases 1986;8(3):329-49.
1986: Myron M Levine
Antimicrobial therapy for infectious diarrhea.
Reviews of infectious diseases 1986;8 Suppl 2():S207-16.
1986: Fred Homa; D J Purifoy; J C Glorioso; Myron M Levine
Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody.
Journal of virology 1986;58(2):281-9.
1986: J R Harris; S D Holmberg; R D Parker; D E Kay; T J Barrett; C R Young; Myron M Levine; P A Blake
Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
American journal of epidemiology 1986;123(3):424-30.
1986: S D Sears; C Ferreccio; Myron M Levine
Sensitivity of Moore sewer swabs for isolating Salmonella typhi.
Applied and environmental microbiology 1986;51(2):425-6.
1986: A Avendano; Pilar Herrera; I Horwitz; E Duarte; I Prenzel; C Lanata; Myron M Levine
Duodenal string cultures: practicality and sensitivity for diagnosing enteric fever in children.
The Journal of infectious diseases 1986;153(2):359-62.
1986: Margaret B Rennels; Myron M Levine
Classical bacterial diarrhea: perspectives and update--Salmonella, Shigella, Escherichia coli, Aeromonas and Plesiomonas.
Pediatric infectious disease 1986;5(1 Suppl):S91-100.
1986: Myron M Levine; Genevieve A Losonsky; D Herrington; James B Kaper; Carol O Tacket; Margaret B Rennels; J Glenn Morris
Pediatric diarrhea: the challenge of prevention.
Pediatric infectious disease 1986;5(1 Suppl):S29-43.
1986: Myron M Levine
Clinical and field trials to assess the efficacy of vaccines against bacterial enteric infections.
Annali Sclavo. Collana monografica 1986;3(1-2):41-50.
1986: R Germanier; Myron M Levine
The live oral typhoid vaccine Ty21a: recent field trial results.
Annali Sclavo. Collana monografica 1986;3(1-2):19-22.
1986: Genevieve A Losonsky; Margaret B Rennels; A Z Kapikian; K Midthun; P J Ferra; D N Fortier; K M Hoffman; A Baig; Myron M Levine
Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
Pediatric infectious disease 1986;5(1):25-9.
1985: B E Murray; T Alvarado; K H Kim; M Vorachit; P Jayanetra; Myron M Levine; I Prenzel; M Fling; L Elwell; G H McCracken
Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.
The Journal of infectious diseases 1985;152(6):1107-13.
1985: G Kümel; H C Kaerner; Myron M Levine; C H Schröder; J C Glorioso
Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
Journal of virology 1985;56(3):930-7.
1985: Claudio F Lanata; James B Kaper; M M Baldini; Robert E Black; Myron M Levine
Sensitivity and specificity of DNA probes with the stool blot technique for detection of Escherichia coli enterotoxins.
The Journal of infectious diseases 1985;152(5):1087-90.
1985: James P Nataro; M M Baldini; James B Kaper; Robert E Black; N Bravo; Myron M Levine
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe.
The Journal of infectious diseases 1985;152(3):560-5.
1985: Myron M Levine; James P Nataro; H Karch; M M Baldini; James B Kaper; Robert E Black; M L Clements; A D O'Brien
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.
The Journal of infectious diseases 1985;152(3):550-9.
1985: Myron M Levine
Escherichia coli infections.
The New England journal of medicine 1985;313(7):445-7.
1985: C H Schröder; J DeZazzo; K W Knopf; H C Kaerner; Myron M Levine; J Glorioso
A herpes simplex virus type 1 mutant with a deletion in the polypeptide-coding sequences of the ICP4 gene.
The Journal of general virology 1985;66 ( Pt 7)():1589-93.
1985: James P Nataro; Isabel C A Scaletsky; James B Kaper; Myron M Levine; Luiz R Trabulsi
Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli.
Infection and immunity 1985;48(2):378-83.
1985: A L Goldin; R M Sandri-Goldin; Joseph C Glorioso; Myron M Levine
Stable induction of a 51K cellular protein in neuronal cells surviving herpes simplex virus type 1 infection.
Virology 1985;142(2):398-405.
1985: B E Murray; Myron M Levine; A M Cordano; K D'Ottone; P Jayanetra; D Kopecko; R Pan-Urae; I Prenzel
Survey of plasmids in Salmonella typhi from Chile and Thailand.
The Journal of infectious diseases 1985;151(3):551-5.
1985: Myron M Levine; C R Young; Robert E Black; Y Takeda; R A Finkelstein
Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.
Journal of clinical microbiology 1985;21(2):174-9.
1985: Robert E Black; L Cisneros; Myron M Levine; A Banfi; H Lobos; H Rodriguez
Case-control study to identify risk factors for paediatric endemic typhoid fever in Santiago, Chile.
Bulletin of the World Health Organization 1985;63(5):899-904.
1985: S D Marlin; Thomas C Holland; Myron M Levine; Joseph C Glorioso
Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
Journal of virology 1985;53(1):128-36.
1984: G E Kikuchi; J E Coligan; Thomas C Holland; Myron M Levine; Joseph C Glorioso; R Nairn
Biochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC molecules.
Journal of virology 1984;52(3):806-15.
1984: J Glenn Morris; C Ferreccio; J Garcia; H Lobos; Robert E Black; H Rodriguez; Myron M Levine
Typhoid fever in Santiago, Chile: a study of household contacts of pediatric patients.
The American journal of tropical medicine and hygiene 1984;33(6):1198-202.
1984: S A Long-Krug; C S Weikel; K T Tiemens; E L Hewlett; Myron M Levine; R L Guerrant
Does enteropathogenic Escherichia coli produce heat-labile enterotoxin, heat-stable enterotoxins a or b, or cholera toxin A subunits?
Infection and immunity 1984;46(2):612-4.
1984: Thomas C Holland; Fred Homa; S D Marlin; Myron M Levine; Joseph C Glorioso
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.
Journal of virology 1984;52(2):566-74.
1984: A M Svennerholm; Myron M Levine; J Holmgren
Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients.
Infection and immunity 1984;45(3):792-4.
1984: I W Booth; Myron M Levine; J T Harries
Oral rehydration therapy in acute diarrhoea in childhood.
Journal of pediatric gastroenterology and nutrition 1984;3(4):491-9.
1984: C Ferreccio; Myron M Levine; A Manterola; G Rodriguez; I Rivara; I Prenzel; Robert E Black; T Mancuso; D Bulas
Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years.
The Journal of pediatrics 1984;104(6):899-901.
1984: J Glorioso; C H Schröder; G Kumel; M Szczesiul; Myron M Levine
Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.
Journal of virology 1984;50(3):805-12.
1984: S D Sears; K Richardson; C Young; C D Parker; Myron M Levine
Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.
Infection and immunity 1984;44(2):439-44.
1984: Myron M Levine; P Ristaino; G Marley; C Smyth; S Knutton; Edgar C Boedeker; Robert E Black; C Young; M L Clements; C Cheney
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.
Infection and immunity 1984;44(2):409-20.
1984: James B Kaper; H Lockman; M M Baldini; Myron M Levine
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.
Nature 1984;308(5960):655-8.
1984: Myron M Levine; Robert E Black; M L Clements; James B Kaper
Present status of cholera vaccines.
Biochemical Society transactions 1984;12(2):200-2.
1984: S D Sears; C Ferreccio; Myron M Levine; A M Cordano; J Monreal; Robert E Black; K D'Ottone; B Rowe
The use of Moore swabs for isolation of Salmonella typhi from irrigation water in Santiago, Chile.
The Journal of infectious diseases 1984;149(4):640-2.
1984: R M Sandri-Goldin; A L Goldin; Joseph C Glorioso; Myron M Levine
Herpes simplex virus thymidine kinase gene is stably maintained and expressed in cells transformed by protoplast fusion.
Somatic cell and molecular genetics 1984;10(2):129-38.
1984: L E Holland; R M Sandri-Goldin; A L Goldin; Joseph C Glorioso; Myron M Levine
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45.
Journal of virology 1984;49(3):947-59.
1984: Myron M Levine; Robert E Black; C Ferreccio
Typhoid vaccines: outlook for the future.
Diarrhoea Dialogue 1984;(16):7.
1984: D Pizarro; G Posada; Myron M Levine
Hypernatremic diarrheal dehydration treated with "slow" (12-hour) oral rehydration therapy: a preliminary report.
The Journal of pediatrics 1984;104(2):316-9.
1984: Myron M Levine; Robert E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.
Infection and immunity 1984;43(2):515-22.
1984: A D O'Brien; M E Chen; R K Holmes; James B Kaper; Myron M Levine
Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
Lancet 1984;1(8368):77-8.
1984: Myron M Levine; D Pizarro
Advances in therapy of diarrheal dehydration: oral rehydration.
Advances in pediatrics 1984;31():207-34.
1984: Myron M Levine; Robert Edelman
Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis.
Epidemiologic reviews 1984;6():31-51.
1983: Myron M Levine; James B Kaper; Robert E Black; M L Clements
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
Microbiological reviews 1983;47(4):510-50.
1983: M L Clements; C L Wisseman; T E Woodward; P Fiset; John Dumler; W McNamee; Robert E Black; J Rooney; T P Hughes; Myron M Levine
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever.
The Journal of infectious diseases 1983;148(5):922-30.
1983: M L Clements; John Dumler; P Fiset; C L Wisseman; M J Snyder; Myron M Levine
Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test.
The Journal of infectious diseases 1983;148(5):876-80.
1983: R M Sandri-Goldin; A L Goldin; L E Holland; Joseph C Glorioso; Myron M Levine
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product.
Molecular and cellular biology 1983;3(11):2028-44.
1983: David N Taylor; J R Harris; T J Barrett; N T Hargrett; I Prentzel; C Valdivieso; C Palomino; Myron M Levine; P A Blake
Detection of urinary Vi antigen as a diagnostic test for typhoid fever.
Journal of clinical microbiology 1983;18(4):872-6.
1983: Myron M Levine; James B Kaper; H Lockman; Robert E Black; M L Clements; S Falkow
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containment.
The Journal of infectious diseases 1983;148(4):699-709.
1983: P A Ristaino; Myron M Levine; C R Young
Improved GM1-enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin.
Journal of clinical microbiology 1983;18(4):808-15.
1983: H W Moon; S C Whipp; Robert A Argenzio; Myron M Levine; R A Giannella
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.
Infection and immunity 1983;41(3):1340-51.
1983: Myron M Levine; James B Kaper; H Lockman; Robert E Black; M L Clements; S Falkow
Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containment.
Recombinant DNA technical bulletin 1983;6(3):89-97.
1983: Claudio F Lanata; Myron M Levine; C Ristori; Robert E Black; L Jimenez; M Salcedo; J Garcia; V Sotomayor
Vi serology in detection of chronic Salmonella typhi carriers in an endemic area.
Lancet 1983;2(8347):441-3.
1983: D Pizarro; G Posada; N Villavicencio; E Mohs; Myron M Levine
Oral rehydration in hypernatremic and hyponatremic diarrheal dehydration.
American journal of diseases of children (1960) 1983;137(8):730-4.
1983: M M Baldini; James B Kaper; Myron M Levine; H W Moon
Molecular nature of adhesion in enteropathogenic Escherichia coli.
Lancet 1983;2(8343):218.
1983: James B Kaper; Myron M Levine
Toxins in environmental Vibrio cholerae.
Lancet 1983;2(8343):217-8.
1983: M L Clements; S O'Donnell; Myron M Levine; R M Chanock; Brian Murphy
Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
Infection and immunity 1983;40(3):1044-51.
1983: Robert Edelman; Myron M Levine
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli.
The Journal of infectious diseases 1983;147(6):1108-18.
1983: Thomas C Holland; R M Sandri-Goldin; L E Holland; S D Marlin; Myron M Levine; Joseph C Glorioso
Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay.
Journal of virology 1983;46(2):649-52.
1983: Joseph C Glorioso; M S Szczesiul; S D Marlin; Myron M Levine
Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
Virology 1983;126(1):1-18.
1983: Myron M Levine
Vaccines to prevent travelers' diarrhea.
Therapeutische Umschau. Revue thérapeutique 1983;40(3):253-6.
1983: A M Svennerholm; J Holmgren; Robert E Black; Myron M Levine; Michael H Merson
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.
The Journal of infectious diseases 1983;147(3):514-22.
1983: Thomas C Holland; S D Marlin; Myron M Levine; Joseph C Glorioso
Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
Journal of virology 1983;45(2):672-82.
1983: Myron M Levine; P Ristaino; RICHARD SACK; James B Kaper; F Orskov; I Orskov
Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type.
Infection and immunity 1983;39(2):889-97.
1983: Myron M Levine; Robert E Black; M L Clements; C R Young; C Lanata; S Sears; T Honda; R Finkelstein
Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
Developments in biological standardization 1983;53():59-65.
1983: M L Clements; Myron M Levine; P A Ristaino; V E Daya; T P Hughes
Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease.
Progress in food & nutrition science 1983;7(3-4):29-37.
1983: M M Baldini; James B Kaper; Myron M Levine; D C Candy; H W Moon
Plasmid-mediated adhesion in enteropathogenic Escherichia coli.
Journal of pediatric gastroenterology and nutrition 1983;2(3):534-8.
1983: R M Sandri-Goldin; A L Goldin; Myron M Levine; Joseph C Glorioso
High-efficiency transfer of DNA into eukaryotic cells by protoplast fusion.
Methods in enzymology 1983;101():402-11.
1983: Richard G Wyatt; Albert Z Kapikian; Harry B Greenberg; A R Kalica; J Flores; Y Hoshino; Robert M Chanock; Myron M Levine
Development of vaccines against rotavirus disease.
Progress in food & nutrition science 1983;7(3-4):189-92.
1983: Robert E Black; Myron M Levine; C Young; J Rooney; S Levine; M L Clements; S O'Donnell; T Hugues; R Germanier
Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.
Developments in biological standardization 1983;53():9-14.
1983: Albert Z Kapikian; Richard G Wyatt; Myron M Levine; Robert E Black; Harry B Greenberg; J Flores; A R Kalica; Y Hoshino; Robert M Chanock
Studies in volunteers with human rotaviruses.
Developments in biological standardization 1983;53():209-18.
1983: A Z Kapikian; Richard G Wyatt; Myron M Levine; Robert H Yolken; D H VanKirk; R Dolin; Harry B Greenberg; R M Chanock
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.
The Journal of infectious diseases 1983;147(1):95-106.
1983: Myron M Levine
Travellers' diarrhoea: prospects for successful immunoprophylaxis.
Scandinavian journal of gastroenterology. Supplement 1983;84():121-34.
1982: Myron M Levine; Robert E Black; C Lanata
Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area.
The Journal of infectious diseases 1982;146(6):724-6.
1982: R M Robins-Browne; Myron M Levine; B Rowe; E M Gabriel
Failure to detect conventional enterotoxins in classical enteropathogenic (serotyped) Escherichia coli strains of proven pathogenicity.
Infection and immunity 1982;38(2):798-801.
1982: T E Hobbins; T P Hughes; Margaret B Rennels; Brian Murphy; Myron M Levine
Bronchial reactivity in experimental infections with influenza virus.
The Journal of infectious diseases 1982;146(4):468-71.
1982: C T Huang; Myron M Levine; G S Daoud; D R Nalin; B L Nichols
Fecal steroids in diarrhea: IV. Cholera.
Lipids 1982;17(9):612-6.
1982: M D Tolpin; M L Clements; Myron M Levine; Robert E Black; A J Saah; WILLIAM ANTHONY; L Cisneros; R M Chanock; Brian Murphy
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses.
Infection and immunity 1982;36(2):645-50.
1982: M L Clements; Myron M Levine; C R Young; Robert E Black; Y L Lim; R M Robins-Browne; J P Craig
Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
The Journal of infectious diseases 1982;145(4):465-73.
1982: Myron M Levine; Robert E Black; M L Clements; L Cisneros; A Saah; D R Nalin; D M Gill; J P Craig; C R Young; P Ristaino
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.
The Journal of infectious diseases 1982;145(3):296-9.
1982: Robert E Black; Myron M Levine; M L Clements; L Cisneros; V Daya
Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.
Reviews of infectious diseases 1982;4(2):540-5.
1982: Myron M Levine; Robert E Black; C C Brinton; M L Clements; P Fusco; T P Hughes; S O'Donnell; R Robins-Browne; S Wood; C R Young
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
Scandinavian journal of infectious diseases. Supplementum 1982;33():83-95.
1981: James B Kaper; Myron M Levine
Cloned cholera enterotoxin genes in study and prevention of cholera.
Lancet 1981;2(8256):1162-3.
1981: Robert E Black; Myron M Levine; M L Clements; P Angle; R Robins-Browne
Proliferation of enteropathogens in oral rehydration solutions prepared with river water from Honduras and Surinam.
The Journal of tropical medicine and hygiene 1981;84(5):195-7.
1981: Myron M Levine
Oral therapy for diarrhoea: past, present and future.
The Journal of tropical medicine and hygiene 1981;84(5):185-7.
1981: M L Clements; Myron M Levine; F Cleaves; T P Hughes; M Caceres; E Aleman; Robert E Black; J Rust
Comparison of simple sugar/salt versus glucose/electrolyte oral rehydration solutions in infant diarrhoea.
The Journal of tropical medicine and hygiene 1981;84(5):189-94.
1981: Myron M Levine; C R Young; T P Hughes; S O'Donnell; Robert E Black; M L Clements; R Robins-Browne; Y L Lim
Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology.
American journal of epidemiology 1981;114(3):348-54.
1981: C T Huang; Myron M Levine; W E Woodward; G S Gopalakrishna; D R Nalin; R B Hornick; B L Nochols
Biohydrogenation of cholesterol as an index of bacterial 7 alpha-dehydroxylase activity.
Lipids 1981;16(9):670-6.
1981: R M Sandri-Goldin; A L Goldin; Myron M Levine; Joseph C Glorioso
High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.
Molecular and cellular biology 1981;1(8):743-52.
1981: M L Clements; Myron M Levine; Robert E Black; R M Robins-Browne; L A Cisneros; George L Drusano; Claudio F Lanata; A J Saah
Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli.
Antimicrobial agents and chemotherapy 1981;20(1):104-8.
1981: Myron M Levine; Robert E Black; M L Clements; L Cisneros; D R Nalin; C R Young
Duration of infection-derived immunity to cholera.
The Journal of infectious diseases 1981;143(6):818-20.
1981: Brian Murphy; R M Chanock; M L Clements; WILLIAM ANTHONY; A J Sear; L A Cisneros; Margaret B Rennels; E H Miller; Robert E Black; Myron M Levine; R F Betts; R G Douglas; H F Maassab; N J Cox; A P Kendal
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.
Infection and immunity 1981;32(2):693-7.
1981: Myron M Levine; M L Clements; Robert E Black; T P Hughes; D Blum; R Andino; G Corrales
A practical, reliable method for preparing simple sugar/salt oral rehydration solution.
The Journal of tropical medicine and hygiene 1981;84(2):73-6.
1981: R M Robins-Browne; Myron M Levine
The fate of ingested lactobacilli in the proximal small intestine.
The American journal of clinical nutrition 1981;34(4):514-9.
1981: A L Goldin; R M Sandri-Goldin; Myron M Levine; Joseph C Glorioso
Cloning of herpes simplex virus type 1 sequences representing the whole genome.
Journal of virology 1981;38(1):50-8.
1981: R M Sandri-Goldin; Myron M Levine; J C Glorioso
Method for induction of mutations in physically defined regions of the herpes simplex virus genome.
Journal of virology 1981;38(1):41-9.
1981: J D Snyder; D T Allegra; Myron M Levine; J P Craig; J C Feeley; W E DeWitt; P A Blake
Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
The Journal of infectious diseases 1981;143(2):182-7.
1981: R M Robins-Browne; Myron M Levine
Effect of chlorpromazine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin and 8-Br-cyclic GMP in infant mice.
Gastroenterology 1981;80(2):321-6.
1981: Myron M Levine
Adhesion of enterotoxigenic Escherichia coli in humans and animals.
Ciba Foundation symposium 1981;80():142-60.
1980: D Pizarro; G Posada; Myron M Levine; E Mohs
Oral rehydration of infants with acute diarrhoeal dehydration: a practical method.
The Journal of tropical medicine and hygiene 1980;83(6):241-5.
1980: M L Clements; Myron M Levine; Robert E Black; T P Hughes; J Rust; F C Tome
Potassium supplements for oral diarrhoea regimens.
Lancet 1980;2(8199):854.
1980: Margaret B Rennels; Myron M Levine; V Daya; P Angle; C Young
Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories.
The Journal of infectious diseases 1980;142(3):328-31.
1980: J C Glorioso; Myron M Levine; Thomas C Holland; M S Szczesiul
Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.
Journal of virology 1980;35(3):672-81.
1980: Myron M Levine; T P Hughes; Robert E Black; M L Clements; S Matheny; A Siegel; F Cleaves; C Gutierrez; D P Foote; W Smith
Variability of sodium and sucrose levels of simple sugar/salt oral rehydrations solutions prepared under optimal and field conditions.
The Journal of pediatrics 1980;97(2):324-7.
1980: Brian Murphy; Margaret B Rennels; R G Douglas; R F Betts; Robert B Couch; Thomas R Cate; R M Chanock; A P Kendal; H F Maassab; S Suwanagool; S B Sotman; L A Cisneros; WILLIAM ANTHONY; D R Nalin; Myron M Levine
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
Infection and immunity 1980;29(2):348-55.
1980: M L Clements; Myron M Levine; Robert E Black; T P Hughes; D R Nalin; D Pizarro; N Hirschhorn
Oral therapy with glucose electrolyte solution.
Lancet 1980;2(8184):34.
1980: Myron M Levine; A L Goldin; J C Glorioso
Persistence of herpes simplex virus genes in cells of neuronal origin.
Journal of virology 1980;35(1):203-10.
1980: Myron M Levine; Margaret B Rennels; V Daya; T P Hughes
Hemagglutination and colonization factors in enterotoxigenic and enteropathogenic Escherichia coli that cause diarrhea.
The Journal of infectious diseases 1980;141(6):733-7.
1980: Myron M Levine; Margaret B Rennels; L Cisneros; T P Hughes; D R Nalin; C R Young
Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact.
American journal of epidemiology 1980;111(3):347-55.
1980: Brian Murphy; L J Markoff; R M Chanock; S B Spring; H F Maassab; A P Kendal; N J Cox; Myron M Levine; R G Douglas; R F Betts; Robert B Couch; Thomas R Cate
Genetic approaches to attenuation of influenza A viruses for man.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1980;288(1029):401-15.
1980: Myron M Levine
Cholera in Louisiana: old problem, new light.
The New England journal of medicine 1980;302(6):345-7.
1980: Roy M Robins-Browne; C R Young; Myron M Levine; J P Craig
Microtiter enzyme-linked immunosorbent assay for immunoglobulin g cholera antitoxin in humans: sensitivity and specificity.
Infection and immunity 1980;27(2):497-500.
1980: C R Young; Myron M Levine; J P Craig; R Robins-Browne
Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.
Infection and immunity 1980;27(2):492-6.
1980: Brian Murphy; R M Chanock; R G Douglas; R F Betts; D H Waterman; H P Holley; D L Hoover; S Suwanagool; D R Nalin; Myron M Levine
Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.
Archives of virology 1980;65(2):169-73.
1980: C T Huang; Myron M Levine; G S Daoud; D R Nalin; B L Nichols
Fecal steroids in diarrhea. III. Experimentally-induced travellers' diarrhea.
The American journal of clinical nutrition 1980;33(1):40-4.
1980: Robert Edelman; Myron M Levine
Acute diarrheal infections in infants I. Bacterial and viral causes.
Hospital practice 1980;15(1):97-104.
1979: Myron M Levine; Robert Edelman
Acute diarrheal infections in infants. I. Epidemiology, Treatment, and prospects for immunoprophylaxis.
Hospital practice 1979;14(12):89-100.
1979: R A Gunn; A M Kimball; R A Pollard; J C Feeley; R A Feldman; S R Dutta; P P Matthew; R A Mahmood; Myron M Levine
Bottle feeding as a risk factor for cholera in infants.
Lancet 1979;2(8145):730-2.
1979: R G Douglas; L J Markoff; Brian Murphy; R M Chanock; R F Betts; F G Hayden; Myron M Levine; G A Van Blerk; S B Sotman; D R Nalin
Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.
Infection and immunity 1979;26(1):274-9.
1979: D R Nalin; V Daya; A Reid; Myron M Levine; L Cisneros
Adsorption and growth of Vibrio cholerae on chitin.
Infection and immunity 1979;25(2):768-70.
1979: D R Nalin; Myron M Levine
Hour of onset of cholera and diarrhoea.
Lancet 1979;2(8132):49-50.
1979: Myron M Levine; D R Nalin; Margaret B Rennels; R B Hornick; S Sotman; G Van Blerk; T P Hughes; S O'Donnell; D Barua
Genetic susceptibility to cholera.
Annals of human biology 1979;6(4):369-74.
1979: Myron M Levine; D R Nalin; D L Hoover; E J Bergquist; R B Hornick; C R Young
Immunity to enterotoxigenic Escherichia coli.
Infection and immunity 1979;23(3):729-36.
1979: Brian Murphy; H P Holley; E J Berquist; Myron M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
Infection and immunity 1979;23(2):253-9.
1979: Brian Murphy; R M Chanock; Myron M Levine; G A van Blerk; E J Berquist; R G Douglas; R F Betts; R B Couch; T R Cate
Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.
Infection and immunity 1979;23(2):249-52.
1979: Myron M Levine; D R Nalin; J P Craig; D Hoover; E J Bergquist; D Waterman; H P Holley; R B Hornick; N P Pierce; J P Libonati
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1979;73(1):3-9.
1979: D R Nalin; Myron M Levine; R B Hornick; E J Bergquist; D Hoover; H P Holley; D Waterman; J VanBlerk; S Matheny; S Sotman; Margaret B Rennels
The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1979;73(1):10-4.
1979: Myron M Levine
Shigella and Salmonella diarrhoeal disease.
Tropical doctor 1979;9(1):4-9.
1979: Harry B Greenberg; Myron M Levine; Michael H Merson; RICHARD SACK; David A Sack; J R Valdesuso; D Nalin; D Hoover; R M Chanock; A Z Kapikian
Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin.
Journal of clinical microbiology 1979;9(1):60-4.
1979: D Pizarro; G Posada; E Mohs; Myron M Levine; D R Nalin
Evaluation of oral therapy for infant diarrhoea in an emergency room setting: the acute episode as an opportunity for instructing mothers in home treatment.
Bulletin of the World Health Organization 1979;57(6):983-6.
1979: D R Nalin; Myron M Levine; L Mata; C de Céspedes; W Vargas; C Lizano; A R Loria; A Simhon; E Mohs
Oral rehydration and maintenance of children with rotavirus and bacterial diarrhoeas.
Bulletin of the World Health Organization 1979;57(3):453-9.
1978: D R Nalin; Myron M Levine; C R Young; E J Bergquist; J C McLaughlin
Increased Escherichia coli enterotoxin detection after concentrating culture supernatants: possible new enterotoxin detectable in dogs but not in infant mice.
Journal of clinical microbiology 1978;8(6):700-3.
1978: D R Nalin; Myron M Levine; J Rhead; E Bergquist; Margaret B Rennels; T Hughes; S O'Donnel; R B Hornick
Cannabis, hypochlorhydria, and cholera.
Lancet 1978;2(8095):859-62.
1978: D R Nalin; R J Levine; Myron M Levine; D Hoover; E Bergquist; J McLaughlin; J Libonati; J Alam; R B Hornick
Cholera, non-vibrio cholera, and stomach acid.
Lancet 1978;2(8095):856-9.
1978: Myron M Levine; Margaret B Rennels
E. coli colonisation factor antigen in diarrhoea.
Lancet 1978;2(8088):534.
1978: D R Nalin; Myron M Levine; L Mata; C de Cespedes; W Vargas; C Lizano; A R Loria; A Simhon; E Mohs
Comparison of sucrose with glucose in oral therapy of infant diarrhoea.
Lancet 1978;2(8084):277-9.
1978: R Adler; J C Glorioso; J Cossman; Myron M Levine
Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis.
Infection and immunity 1978;21(2):442-7.
1978: Myron M Levine; O Grados; Robert H Gilman; W E Woodward; R Solis-Plaza; W Waldman
Diagnostic value of the Widal test in areas endemic for typhoid fever.
The American journal of tropical medicine and hygiene 1978;27(4):795-800.
1978: Myron M Levine; T P Hughes; C R Young; S O'Donnell; J P Craig; H P Holley; E J Bergquist
Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
Infection and immunity 1978;21(1):158-62.
1978: Brian Murphy; L J Markoff; N T Hosier; H M Rusten; R M Chanock; A P Kendal; R G Douglas; R F Betts; T R Cate; R B Couch; Myron M Levine; D H Waterman; H P Holley
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers.
Infection and immunity 1978;20(3):671-7.
1978: Myron M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.
Lancet 1978;1(8074):1119-22.
1978: E R Wald; Myron M Levine
Haemophilus influenzae type b pneumonia.
Archives of disease in childhood 1978;53(4):316-8.
1978: R Adler; J C Glorioso; Myron M Levine
Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.
The Journal of general virology 1978;39(1):9-20.
1978: S Weaver; Myron M Levine
Replication in situ and DNA encapsulation following induction of an excision-defective lysogen of Salmonella bacteriophage P22.
Journal of molecular biology 1978;118(3):389-411.
1977: Robert H Gilman; R B Hornick; W E Woodard; H L DuPont; M J Snyder; Myron M Levine; J P Libonati
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.
The Journal of infectious diseases 1977;136(6):717-23.
1977: Myron M Levine; T P Hughes; P Simon; S O'Donnell; S Grauel; S G Levine
Monovalent inactivated A/New Jersey/8/76 (Hsw1N1) vaccine in healthy children aged three to five years.
The Journal of infectious diseases 1977;136 Suppl():S571-4.
1977: Ellis Caplan; T P Hughes; S O'Donnel; Myron M Levine; R B Hornick
Reactogenicity and immunogenicity of parenteral monovalent influenza A/Victoria/3/75 (H3N2) virus vaccine in healthy adults.
The Journal of infectious diseases 1977;136 Suppl():S484-90.
1977: Myron M Levine; W E Woodward; S B Formal; P Gemski; H L DuPont; R B Hornick; M J Snyder
Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.
The Journal of infectious diseases 1977;136(4):577-82.
1977: D D Richman; Brian Murphy; R B Belshe; H M Rusten; R M Chanock; N R Blacklow; Thomas Parrino; F B Rose; Myron M Levine; Ellis Caplan
Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adults.
The Journal of infectious diseases 1977;136(2):256-62.
1977: Myron M Levine; Ellis Caplan; D Waterman; R A Cash; R B Hornick; M J Snyder
Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.
Infection and immunity 1977;17(1):78-82.
1977: S Weaver; Myron M Levine
Recombinational circularization of Salmonella phage P22 DNA.
Virology 1977;76(1):29-38.
1977: S Weaver; Myron M Levine
The timing of erf-mediated recombination in replication, lysogenization, and the formation of recombinant progeny by Salmonella phage P22.
Virology 1977;76(1):19-28.
1976: D D Richman; Brian Murphy; R M Chanock; J M Gwaltney; R G Douglas; R F Betts; N R Blacklow; F B Rose; Thomas Parrino; Myron M Levine; Ellis Caplan
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults.
The Journal of infectious diseases 1976;134(6):585-94.
1976: R M Miller; J Garbus; A R Schwartz; H L DuPont; Myron M Levine; D F Clyde; R B Hornick
A modified leukocyte nitroblue tetrazolium test in acute bacterial infection.
American journal of clinical pathology 1976;66(5):905-10.
1976: Myron M Levine; E J Gangarosa; W B Barrow; C F Weiss
Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease.
American journal of epidemiology 1976;104(1):88-92.
1976: Myron M Levine; H L DuPont; R B Hornick; M J Snyder; W Woodward; Robert H Gilman; J P Libonati
Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization.
The Journal of infectious diseases 1976;133(4):424-9.
1976: E R Wald; Myron M Levine
Frequency of detection of Hemophilus influenzae type b capsular polysaccharide in infants and children with pneumonia.
Pediatrics 1976;57(2):266-8.
1976: G T Keusch; M Jacewicz; Myron M Levine; R B Hornick; S Kochwa
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1.
The Journal of clinical investigation 1976;57(1):194-202.
1976: R B Hornick; H L DuPont; Myron M Levine; Robert H Gilman; W E Woodward; M J Snyder; T E Woodward
Efficacy of a live oral typhoid vaccine in human volunteers.
Developments in biological standardization 1976;33():89-92.
1975: B Hoffman; Myron M Levine
Bacteriophage P22 virion protein which performs an essential early function. II. Characterization of the gene 16 function.
Journal of virology 1975;16(6):1547-59.
1975: B Hoffman; Myron M Levine
Bacteriophage P22 virion protein which performs an essential early function. I. Analysis of 16-ts mutants.
Journal of virology 1975;16(6):1536-46.
1975: Robert H Gilman; M Terminel; Myron M Levine; P Hernandez-Mendosa; E Calderone; V Vasquez; E Martinez; M J Snyder; R B Hornick
Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever.
The Journal of infectious diseases 1975;132(6):630-6.
1975: Myron M Levine; R B Hornick
Lactulose therapy in Shigella carrier state and acute dysentery.
Antimicrobial agents and chemotherapy 1975;8(5):581-4.
1975: Robert H Gilman; M Terminel; Myron M Levine; P Hernandez-Mendoza; R B Hornick
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever.
Lancet 1975;1(7918):1211-3.
1974: Myron M Levine; Y Togo; E R Wald
Practicability of influenza surveillance by virus culture of children.
American journal of epidemiology 1974;100(4):272-6.
1974: Myron M Levine
Live-virus vaccines in pregnancy. Risks and recommendations.
Lancet 1974;2(7871):34-8.
1974: Myron M Levine; E J Gangarosa; M Werner; G K Morris
Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
The Journal of pediatrics 1974;84(6):803-6.
1974: Myron M Levine; P A Rice; E J Gangarosa; G K Morris; M J Snyder; S B Formal; J G Wells; P Gemski; J Hammond
An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
American journal of epidemiology 1974;99(1):30-6.
1973: E R Wald; Myron M Levine; Y Togo
Concomitant varicella and staphylococcal scalded skin syndrome.
The Journal of pediatrics 1973;83(6):1017-9.
1973: G W Wertz; Myron M Levine
RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide.
Journal of virology 1973;12(2):253-64.
1973: Myron M Levine; H L DuPont; M Khodabandelou; R B Hornick
Long-term Shigella-carrier state.
The New England journal of medicine 1973;288(22):1169-71.
1973: Myron M Levine; H L DuPont; S B Formal; R B Hornick; A Takeuchi; E J Gangarosa; M J Snyder; J P Libonati
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery.
The Journal of infectious diseases 1973;127(3):261-70.
1973: M J Bronson; Myron M Levine
A component mutation of virB virulence affects lysogenization by phage P22.
Virology 1973;51(2):504-5.
1972: V Israel; H Rosen; Myron M Levine
Binding of bacteriophage P22 tail parts to cells.
Journal of virology 1972;10(6):1152-8.
1972: Myron M Levine; H L Dupont; E J Gangarosa; R B Hornick; M J Snyder; J P Libonati; K Glaser; S B Formal
Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.
American journal of epidemiology 1972;96(1):40-9.
1972: V Israel; M Woodworth-Gutai; Myron M Levine
Inhibitory effect of bacteriophage P22 infection on host cell deoxyribonuclease activity.
Journal of virology 1972;9(5):752-7.
1972: M Woodworth-Gutai; V Israel; Myron M Levine
New deoxyribonuclease activity after bacteriophage P22 infection.
Journal of virology 1972;9(5):746-51.
1972: M J Bronson; Myron M Levine
Virulent mutants of phage P22. II. Physiological analysis of P22 virB-3 and its component mutations.
Virology 1972;47(3):644-55.
1971: D F Clyde; R M Miller; A R Schwartz; Myron M Levine
Treatment of falciparum malaria with sulfalene and trimethoprim.
The American journal of tropical medicine and hygiene 1971;20(6):804-10.
1971: O F Darlington; Myron M Levine
Superinfection exclusion by P22 prophage and the replication complex.
Journal of virology 1971;8(3):347-8.
1971: M J Bronson; Myron M Levine
Virulent mutants of bacteriophage p22.I. Isolation and genetic analysis.
Journal of virology 1971;7(5):559-68.
1970: Myron M Levine; M Chakravorty; M J Bronson
Control of the replication complex of bacteriophage P22.
Journal of virology 1970;6(4):400-5.
1970: Myron M Levine; H L DuPont; S B Formal; E J Gangarosa
Epidemic Shiga dysentery in Central America.
Lancet 1970;2(7673):607-8.
1970: M Chakravorty; Myron M Levine
Absence of immunity to superinfection in spheroplasts of a lysogen.
Journal of virology 1970;5(2):264-5.
1968: J P Wing; Myron M Levine; Hamilton O Smith
Recombination-deficient mutant of Salmonella typhimurium.
Journal of bacteriology 1968;95(5):1828-34.
1967: Hamilton O Smith; Myron M Levine
A phage P22 gene controlling integration of prophage.
Virology 1967;31(2):207-16.
1966: L W Cohen; Myron M Levine
Detection of proteins synthesized during the establishment of lysogeny with phage P22.
Virology 1966;28(2):208-13.
1965: Hamilton O Smith; Myron M Levine
Gene order in prophage P22.
Virology 1965;27(2):229-31.
1965: Hamilton O Smith; Myron M Levine
THE SYNTHESIS OF PHAGE AND HOST DNA IN THE ESTABLISHMENT OF LYSOGENY.
Virology 1965;25():585-90.
1964: Myron M Levine; Hamilton O Smith
SEQUENTIAL GENE ACTION IN THE ESTABLISHMENT OF LYSOGENY.
Science (New York, N.Y.) 1964;146(3651):1581-2.
1964: Hamilton O Smith; Myron M Levine
TWO SEQUENTIAL REPRESSIONS OF DNA SYNTHESIS IN THE ESTABLISHMENT OF LYSOGENY BY PHAGE P22 AND ITS MUTANTS.
Proceedings of the National Academy of Sciences of the United States of America 1964;52():356-63.
1963: Myron M Levine; M BORTHWICK
THE ACTION OF STREPTONIGRIN ON BACTERIAL DNA METABOLISM AND ON INDUCTION OF PHAGE PRODUCTION IN LYSOGENIC BACTERIA.
Virology 1963;21():568-74.
1961: Myron M Levine; Roy Curtis
Genetic fine structure of the C region and the linkage map of phage P22.
Genetics 1961;46():1573-80.
1961: Myron M Levine
Effect of mitomycin C on interactions between temperate phages and bacteria.
Virology 1961;13():493-9.
1960: Myron M Levine; Roy Curtis
An effect of chloramphenicol on genetic recombination and selection in phage.
Virology 1960;10():370-1.
1958: Myron M Levine; Roy Curtis
A genetic test for side-chains in a phage chromosome.
Nature 1958;182(4628):126-7.
1957: Myron M Levine
Mutations in the temperate phage P22 and lysogeny in Salmonella.
Virology 1957;3(1):22-41.